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I. LITERATURE REVIEW 
1 
A. Serum Cholesterol, Lipoproteins and Atherogenesis 
Historically, most workers in the atherosclerosis area see choles-
terol as a focal element in the etiology of cardiovascular disease. In 
1910, the presence of cholesterol in the lesions of diseased arteries was 
described (1). Since then many studies have confirmed that both free and 
esterified cholesterol accumulate in the aorta, coronary arteries, cerebral 
vessels, and other large arteries at different rates in different persons 
or in different populations. Epidemiological studies have repeatedly 
shown high degrees of correlation between the intake of cholesterol and 
other lipids with the prevalence of coronary heart disease in various pop-
ulations (2). Animal studies show that experimentally-induced hypercholes-
terolemia is followed by the accumulation of cholesterol in the large ar-
teries, and that under c'ertain conditions even more advanced manifestations 
of atherosclerosis are produced (3). Finally, recent work on cultured cells 
shows that certain lipoproteins from normal or hypercholesterolemia serum 
are rapidly taken up by arterial smooth muscle and endothelial cells (4, 5) 
end by skin fibroblasts (6). 
The LDL is the primary carrier of cholesterol in the plasma of persons 
with plasma cholesterol concentrations higher than 150 mg/dl. The apopro-
tein of LDL, apo-B, is found in the arterial lesion (7, 8). Familial hyper-
betalipoproteinemia, in which high levels of LDL are present, is associated 
with premature arteriosclerosis and coronary heart disease. The LDL frac-
tion is usually elevated in experimental animals that eat atherogenic diets 
(6). 
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The role of very low density lipoproteins (VLDL) in atherogenesis is 
not as well established. Some epidemiological studies, however, have 
shown significant correlations between hypertriglyceridemia and coronary 
heart disease (9). The apoproteins characteristic of VLDL (apo-C and 
apo-B) have been found in human arterial lesions (7, 10). Plasma VLDL 
is the precursor of plasma LDL (11, 12) and it may be atherogenic. 
The idea that chylomicrons could be atherogenic has been proposed by 
Zilversmit. This theory is based on the hypothesis that the interaction 
of triglyceride-rich lipoproteins with arterial lipoprotein lipase is an 
atherogenic process (13). The process is assumed to involve the binding 
of chylomicrons to the arterial surface, the hydrolysis of triglyceride by 
arterial lipoprotein lipase and the subsequent internalization of cholesterol-
enriched chylomicron remnants by the arterial smooth muscle cells. It is 
the chylomicron remnant, then, which is thought to be atherogenic. 
B. Lipoprotein Metabolism 
1. Interconversions of Lipoproteins 
Lipoprotein particles are the major transport vehicles of fat sol-
uble materials in the circulation. All lipoproteins are discrete particles 
with finite dimensions and compositions and are frequently characterized as 
such. However, it should be remembered that all plasma lipoproteins are 
metabolically related and that the interaction of single particles with one 
another is perhaps the best physiological approach in understanding lipopro-
tein metabolism. 
The various plasma lipoproteins are probably derived from the liver 
and the intestine. Both of these tissues normally produce triglyceride-rich 
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lipoproteins. The liver secretes VLDL in response to a dietary load of 
either carbohydrate or fatty acids, while the intestine responds to the 
presence of dietary fat by secreting chylomicrons. These lipoproteins are 
rich in triglyceride but also contain free and esterified cholesterol, 
phospholipids and various apoproteins. One apoprotein (apo B protein, 
apo-LDL) appears to be an integral part of the lipoprotein, while the 
other proteins, and lipids as well, are subject to exchange or transfer 
to other lipoprotein complexes (14, 15). Free cholesterol readily ex-
changes between all lipoproteins and between lipoprotein and cell membranes 
as well (16). The cholesteryl ester may require a plasma protein to effect 
exchange (17, 18) or transfer (19). Phospholipids exchange via a plasma 
protein fraction as well (20). The apolipoprotems (apo A-I, apo E or 
arginine-rich, and apo C) seem to move freely from one lipoprotein to 
another (14, 22). Some of these apolipoproteins are co-factors in the 
degradation of triglyceride-rich lipoproteins and then appear to be deliv-
ered to the higher density fractions (23) and are used again via transfer 
to a newly secreted VLDL or chylomicron (14). 
A precursor-product relationship has been known to exist between VLDL 
and LDL for some time (24). In normal individuals the interaction of VLDL 
with LPL seems to give rise to an intermediate density fraction (IDL or 
LDL^) which is further degraded by a less well-defined pathway possibly 
involving lecithin-cholesterol acyl transferase (LCAT). In normal individ-
uals, the flux of apo B through these three fractions is approximately equal, 
indicating the existence of a possible quantitative conversion. In hyper-
trlglyceridemic subjects, the apo B flux in VLDL exceeds that in the LDL 
fraction, suggesting that a part of the VLDL or IDL may be removed by another 
pathway (25). 
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When VLDL proteins are radiolabeled, a transient appearance of the 
label has been found in a lipoprotein of intermediate density between VLDL 
and LDL (IDL, LDL, 1.006 < d < 1.019 g/ml) (26). Thus it appears that the 
intermediate particle formed during the catabolism of triglyceride-rich 
lipoproteins exists as a free lipoprotein complex in plasma. Since LPL 
contains only a single active site per molecule (27), and since many mole-
cules of triglyceride are contained in the triglyceride-rich lipoproteins, 
these intermediates are expected to occur. The triglyceride-depleted par-
ticles formed in this fashion are called remnant lipoproteins. 
Various techniques have been used to investigate the character of 
these remnant particles. All have involved the isolation of the peripheral 
LPL system from the hepatic one allowing the accumulation of the remnant 
fraction. The functionally hepatectomized rat has been used to produce 
large amounts of remnant lipoproteins (20, 28), but this technique is 
limited by the presence of endogenous triglyceride-rich lipoproteins which 
may contaminate this system. A second method involves the use of whole 
organ perfusions, especially heart and adipose tissues (29, 30, 31). Al-
though these procedures allow the use of well-defined systems, the amount 
of remnant lipoproteins produced is small. Another approach has involved 
using either purified LPL (32) or whole post-heparin plasma (15) with the 
in vitro incubation of isolated chylomicrons or VLDL. While large amounts 
of remnants can be produced in this way, in the case of whole post-heparin 
plasma, triglyceride hydrolysis is due to a mixture of lipases including the 
hepatic lipase which appears to play no direct role in remnant formation. 
Lastly, a combination of functionally hepatectomized animals and in vitro 
post-heparin plasma-lipoprotein incubations may serve to eliminate the 
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hepatic-lipase activity and allow the preparation of remnant lipoprotein 
in sufficient quantities to characterize. This technique, used in the 
present studies, may also shed further light on the role of the hepatic 
lipase in remnant formation by comparing post-heparin plasma lipase rem-
nant production between intact and functionally hepatectomized animals. 
Since apo C lipoproteins are known to recycle between triglyceride-
rich lipoproteins and HDL particles, remnants would be expected to become 
depleted of the C peptides. This depletion has been shown to occur in the 
rat (20). The apo B and apo E proteins appear to be retained. The choles-
teryl ester component has not been demonstrated to be a substrate for lipo-
lysis by lipase enzymes but phospholipids (i.e. phosphatidyl choline and 
phosphatidyl ethanolamine) may be attacked by a phospholipase 
present in the LPL system (33, 34). As a result, remnant phospholipids 
become relatively enriched in sphingomyelin. The rates of this phospho-
lipase activity are not high when compared with the lipase activities. Yet 
they may be significant when considered in terms of surface-volume relation-
ships of the lipoproteins since the phospholipid makes up most of the sur-
face of the VLDL and chylomicron while the triglycerides make up a large 
portion of the core of these particles (35). This phospholipase activity, 
then, may play an important role in maintaining the spherical nature of the 
triglyceride-rich particle during triglyceride hydrolysis. A loss of VLDL 
lecithin has been shown to occur (36) in the whole post-heparin plasma 
case, but it should be remembered that post-heparin plasma contains the 
hepatic lipase which has distinct phospholipase activity (37). Furthermore, 
phospholipid is able to freely exchange between VLDL and HDL during trigly-
ceride hydrolysis in vivo (38). Thus, some phospholipid may be lost in this 
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fashion as well. Whatever mechanisms are involved, remnants are signif-
icantly depleted of triglyceride, phospholipid and protein and retain 
most of their cholesterol and cholesteryl esters. 
2. Chylomicron Clearance 
The sequence of events in the conversion of VLDL to LDL and the 
possible removal of excess IDL from plasma appears to have a parallel in 
chylomicron metabolism. The chylomicrons formed in the intestinal mucosal 
cells in response to dietary fat are carried via the lymphatic system to 
the thoracic duct. These particles are subsequently mixed with the com-
ponents of the circulatory system at the subclavian vein. The nature of 
these particles depends on both the nature and the availability of the 
lipids in the intestinal lumen (39, 40) and the protein synthesizing cap-
abilities of the intestinal mucosal cells (41, 42, 43). Zilversmit et al. 
(44) has summarized the relationship of dietary fat to chylomicron size 
distribution on the basis of the relative rates of triglyceride transport 
per mucosal cell and the synthetic rates of the surface material. Their 
conclusions were that lymph chylomicrons are larger, (1) during the absorp-
tion of a high fat meal than during a low fat meal, (2) during peak fat ab-
sorption periods, (3) during the absorption of unsaturated fats than during 
saturated fat absorption, and (42) when protein synthesis is inhibited. 
After the secretion of the chylomicrons from the gut, they contain 
the apolipoproteins, apo A-I, apo A-II, apo B, and possibly others. Then 
upon their entry into the circulation, they acquire apoproteins C and E, 
and are degraded by lipoprotein lipase activity in conjunction with apo C-II 
(45). During this process, the chylomicron loses its major component, 
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triglyceride. Concomittant with this removal, the particle also loses 
surface components such as apo A-I, apo A-II, and phospholipids. The 
triglyceride-depleted particle which remains is also referred to as a rem-
nant. These remnants containing high levels of cholesteryl esters and apo 
B protein are thought to be taken up by the liver (46, 47, 48). In this 
way, either dietary cholesterol or intestinally-synthesized cholesterol can 
enter the liver and take part in the regulation of endogenous cholesterol 
synthesis. 
3. Enzymes of Lipid Metabolism in Plasma 
a. Triacylglycerol Hydrolases 
The intravenous injection of heparin causes the rapid release of lipo-
lytic activity into plasma which is active against triglyceride-rich lipo-
proteins or certain long-chain triglyceride emulsions to which specific 
apolipoproteins (apo C-II) have been added. This enzyme activity has been 
termed "clearing factor lipase", or "lipoprotein lipase" (LPL) (EC 3.1.1.3) 
(49). Post-heparin plasma is now known to contain at least two distinct 
types of hydrolases for long-chain triglycerides, one or more "peripheral" 
lipoprotein lipases which are primarily active against native chylomicrons, 
VLDL, and apo C-II activated triglyceride emulsions and an hepatic lipase 
which is more active against lipid emulsions in the absence of apo C-II. 
In comparison to hepatic lipase, the peripheral LPL is inhibited by 
polycations such as protamine and by molar sodium chloride. Additionally, 
the physical and chemical nature of the substrate is important in differen-
tiating the two activites (50, 51). The peripheral enzyme is activated by 
apo C-II (52) and it is inhibited by protamine sulfate, which has provided 
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an empirical method for quantifying the two activites in post-heparin plasma 
from rats (53) and man (54). 
The hepatic triglyceride hydrolase is enzymologically distinct from 
peripheral LPL (55, 56). The hepatic enzyme attacks some artificial sub-
strates which are poor substrates for the peripheral LPL. VLDL and chylo-
microns, which are readily degraded by the peripheral LPL, are poor sub-
strates for the hepatic lipase (55). Protamine and molar sodium chloride 
do not inhibit the hepatic enzyme as they do the peripheral lipase and no 
co-factor requirement has been demonstrated for the hepatic lipase. In ad-
dition, some evidence indicates that the hepatic enzyme is responsible for 
the hydrolysis of the 2-monoglyceride residue which is the major product of 
peripheral LPL against the triglyceride substrate (50). 
Triglyceride hydrolases from other tissues studied are enzymologically 
similar to the peripheral LPL (57, 58), though the number of distinct molec-
ular species remains uncertain. In adipose tissue, two forms of peripheral 
LPL with different apparent molecular weights have been extracted (59). 
The precise enzymological determination of the relative contribution of 
hepatic and peripheral LPL activities in post-heparin plasma is difficult, 
especially since the activities of the two enzymes are affected by the 
physical nature of the substrate employed (50, 51). Yet the method devised 
by Krauss et al. (53) to selectively measure these two types of activity 
has been used with some utility in the rat (53), dog (60), and man (54), 
and does provide a reasonable estimate of the contributions of each enzyme 
to the total post-heparin plasma activity. 
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b. The Cholesterol Acylating System 
The enzyme, lecithin-cholesterol acyl transferase (EC 2.3.1.43) (LCAT), 
is the major source of plasma cholesteryl ester production in man. This 
enzyme catalyzes the transfer of the C-2 fatty acyl chain from lecithin 
to cholesterol yielding the cholesteryl ester (61). In addition to main-
taining normal plasma lipoprotein composition and structure, LCAT may have 
a role in cholesterol transport. LCAT, by reducing the content of free 
cholesterol on the surface of its natural substrate, HDL, allows additional 
free cholesterol to be transferred from the membrance of peripheral tissues 
to the HDL. The esterified cholesterol produced in this way can then be 
transported to the liver and further catabolized (63). 
In addition, the catabolism of the triglyceride-rich lipoproteins may 
require both lipoprotein lipase (LPL) and LCAT. As LPL reduces the size of 
the neutral lipid core of either chylomicrons or VLDL, an excess of surface 
components may be created (i.e. phospholipid and free cholesterol). LCAT 
may act in concert with LPL to then reduce the excess phospholipid and 
cholesterol on the surface of these particles, since the neutral cholesteryl 
ester would be transferred to the interior of the lipoprotein in question 
(64). Another possibility is that as the triglycerides are removed, their 
core volume is reduced and the excess surface components form bilayer lipid 
folds. These folds form disc-like particles or vesicles on which LCAT can 
act to make spherical HDL. 
In the rabbit, however, it appears that plasma LCAT activity is less 
significant. Rose (62) has concluded that LCAT is probably not responsible 
for the increase in cholesteryl esters in the blood of cholesterol-fed 
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rabbits. These esters appear to be synthesized at sites other than the 
circulation, presumably the liver and intestinal tract. 
C. The Hepatic Metabolism of Free Fatty Acids 
The free fatty acid (FFA) available to the liver in a normal animal can 
be derived from exogenous or endogenous sources. In the fasting or fat-free 
fed state, the major source of FFA is probably adipose tissue triglycerides 
or carbohydrates. In the fed state, especially in high fat diets, the pri-
mary source of plasma FFA is dietary triglycerides (47). When animals or 
man are fed a high fat diet of a particular fatty acid composition, the plasma 
FFA and plasma and hepatic triglyceride become enriched in the fed fatty acid 
within a short time. Since the triglyceride fatty acids of adipose tissue 
appear to turn over at a slower rate than those of liver or plasma (48, 65), 
the composition of the plasma FFA therefore reflects the composition of in-
gested triglyceride. 
The FFA taken up by the liver is primarily esterified to triglyceride. 
To a lesser extent it may be incorporated into phospholipid or cholesteryl 
esters. Depending upon the metabolic needs of the animal, it may also be 
oxidized to CO2 and ketone bodies. The triglycerides formed will then be 
either stored in the liver or secreted into the plasma as the major constit-
uent of the VLDL in conjunction with other lipid and protein components. 
D. The Regulation of Hepatic Cholesterogenesis by Free Fatty Acids 
As triglycerides are secreted by the liver in the VLDL fraction, phos-
pholipids, cholesterol and proteins are also secreted in certain specific 
proportions. These other lipids are important in stabilizing the spherical 
nature of the VLDL particle and to allow the hydrophobic triglyceride to 
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exist in the aqueous plasma compartment. The specific molar ratios of 
phospholipid and cholesterol related to triglyceride have been shown to be 
altered by various factors. The structure and quantity of FFA (66), the 
rate of triglyceride output by the liver (66) , the sex of the animal (67), 
and fat feeding (68) all have been shown to alter this ratio. Further, 
when oleic acid was added to the perfusate of isolated rat livers, the in-
corporation of HHLO in cholesterol was stimulated. Additionally (69), the 
activity of hepatic 3-hydroxy-3 methylglutarate (HMG)-CoA reductase 
(EC 1.1.1.34), the rate limiting step in cholesterol biosynthesis (70), was 
also stimulated. When exogenous cholesterol was added to the medium along 
with the oleate, HMG-CoA reductase activity was depressed while the output 
of triglyceride continued with little change (71). Thus dietary cholesterol 
appears to inhibit or regulate hepatic cholesterogenesis. 
When other fatty acids were used in the medium, the output of cholesterol 
was in the order 18:1 > 18:2 = 16:0 and the output of triglyceride was in 
the order 18:1 = 18:2 > 16:0. This work (72) has suggested that the molar 
ratio of cholesterol to triglyceride in the secreted particle was greater 
when palmitic acid (16:0) was the substrate than when either oleic or linoleic 
acids were infused. In summary then, it appears that not only do plasma FFA 
stimulate cholesterogenesis, but the specific type of FFA have varying ef-
fects on this stimulation as well. 
E. Characteristics of Cholesterol-Induced Hyperlipoproteinemia in Animals 
and Man: Current Theories 
Five major changes have been consistently observed after cholesterol 
feeding (60). These changes are: 1) the occurrence of cholesterol-enriched 
VLDL (B-VLDL); 2) an increase in IDL (d = 1.006-1.019 g/ml); 3) an increase 
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in LDL; 4) the occurrence of HDLC; and 5) a decrease in typical HDL. The 
B-VLDL have been defined as g-migrating lipoproteins which float at d < 1.006 
g/ml by preparative ultracentrifugation. The apoproteins of these cholesterol-
rich B-VLDL undergo changes as well, being relatively high in the arginine-
rich lipoprotein (73, 74), and are comparable to the situation seen in human 
patients with type III hyperlipoproteinemia (73, 75, 76). In this disease, 
there are abnormally high levels of LDL2 (1.019 < d < 1.063 g/ml) and 
triglyceride-poor cholesteryl ester-enriched VLDL. 
The HDLC seen in cholesterol-fed animals has characteristics in common 
with both LDL and the typical HDL. As the plasma cholesterol level increases, 
HDLC become richer in cholesteryl esters and float at lower densities. The 
HDLC particles are similar to LDL with respect to composition and size, but 
are quite different with respect to apoprotein content, since HDLC lack the 
B apoprotein (apo LDL) and primarily contain the arginine-rich protein (apo E) 
and apo A-I. 
The origin of HDLC is undetermined. It may be a remnant of intestinal 
lipoproteins or it may be due to an overloading of typical HDL with cholesterol 
(60). 
A number of possible origins for the cholesterol-induced B-VLDL have 
been suggested. They may be directly synthesized by intestinal mucosa cells 
in response to cholesterol feeding. Yet evidence from the analysis of thoracic 
duct lymph from the cholesterol-fed dog indicates that only large triglyceride-
rich particles are present in the d < 1.006 g/ml fraction (60). A second pos-
sible explanation is that the B-VLDL and IDL are remnants of cholesterol in-
duced intestinal or liver lipoproteins. This theory is supported by the work 
of Zilversmit et al. (21). Their data in the cholesterol-fed rabbit indicates 
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that nearly two-thirds of the esterified cholesterol in the d < 1.006 g/ml 
fraction is derived from chylomicrons. They therefore concluded that the 
metabolic origin of hypercholesterolemia VLDL cholesteryl esters is derived 
from dietary sources, which has helped substantiate the chylomicron remnant 
hypothesis of atherogenesis. Additionally, there appears to be a defect 
in the removal of chylomicron remnants from the plasma of hypercholes-
terolemia rabbits (21). Therefore, the B-VLDL and IDL of cholesterol-fed 
animals may represent products of catabolism due to the action of triglyc-
eride lipases on lipoproteins of intestinal origin. 
Furthermore, Mahley et al. studied a large number of lipoprotein 
changes in dogs treated with cholesterol, bile acids and a thyroid inhib-
itor (79). These authors also have suggested that in the hyperresponders 
the B-VLDL are probably chylomicron remnants which have accumulated due to 
a defective catabolism of the lipoprotein synthesized to carry the excess 
dietary cholesterol. Their conclusion, however, does not necessarily state 
that the B-VLDL are chylomicron remnants. Changes in triglyceride lipase 
activities accompanying cholesterol feeding in these same dogs have also 
been measured (66). The most significant change in lipolytic activity in 
the experiments is a reduction in the hepatic lipase activity in the case 
of the cholesterol-induced hyperlipoproteinemia. Whether these preliminary 
findings suggest a catabolic defect in the hyperresponders that may ex-
plain the differences between the two groups of dogs remains to be deter-
mined . 
Contrary to the remnant hypothesis of Zilversmit, Shore et al. have 
proposed an explanation for the origin of B-VLDL in type III and hypothyroid 
subjects and in cholesterolemic rabbits as well (78). In these conditions 
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LDL2 (probably a product of VLDL catabolism) has relatively more of the 
arginine-rich protein than usual. The LDL2, however, often contain very 
little of the arginine-rich protein and relatively more of the other VLDL 
protein (e.g. apo B and apo C peptides). If the arginine-rich protein is 
present in relatively small amounts in the serum VLDL, it is likely to be 
present only in very small amounts in the LDL2, even if the LDL2 are ele-
vated (74). The rabbits fed excess cholesterol appear to synthesize con-
siderable quantities of triglyceride-poor VLDL that are very rich in this 
protein. In addition, these particles are as large or larger than the 
triglyceride-rich VLDL—not smaller as would be expected if they were 
"remnants" of the triglyceride-rich particle. Consequently these authors 
have concluded that the arginine-rich B-VLDL may be derived from a unique 
VLDL species, enriched in the arginine-rich protein and probably derived 
by synthetic processes in the liver. 
F. The Effect of Cholesterol-Free, High-Fat, Semi-Synthetic Diets in the 
Rabbit Atherosclerosis Model 
In contrast to diets containing supplementary cholesterol, hypercholes-
terolemia has also been described in rabbits fed certain semi-synthetic 
diets devoid of exogenous cholesterol (80-83) and containing saturated fat. 
While the atherogenicity of this type of diet has been studied in some 
depth (84-87), the effect of it on the serum lipoproteins of rabbits has 
not previously been reported. The present studies, therefore, were under-
taken in order to see what effect semi-synthetic diets, containing no choles-
terol and high in either saturated or unsaturated fat would have on the 
serum lipid and lipoprotein concentrations in the rabbit. Also, whether 
similar lipoprotein alterations analogous to those seen in cholesterol-
induced hyperlipoproteinemia exist were to be investigated. 
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Lastly, in order to shed further light on the subject of normal and 
altered VLDL catabolism, experiments utilizing both hepatic and peripheral 
triglyceride lipase preparations and the in vitro production of VLDL rem-
nants were accomplished. The effect of the diets on these parameters was 
also studied. 
II. MATERIALS AND METHODS 
A. Preparation of Egg Yolk Phosphatidylcholine 
Egg phosphatidylcholine was prepared according to the method of 
Singleton et al. (88). One liter of acetone was added to 500 g of fresh 
egg yolk, and the mixture was blended in a Sorvall Omni-Mixer (Model 17105, 
Instrument Products Division, Sorvall Operations, Newtown, Conn.) at 25°C. 
The mixture was allowed to stand for 30 minutes, filtered and the acetone 
extract was discarded. The remaining solids were washed 3 times with 200 ml 
of cold acetone, and then suspended in 1 liter of 95% ethanol. After stand-
ing 1 hour, the mixture was filtered and the extraction was repeated with 
500 ml of 95% ethanol. The combined extracts were dried under vacuum, and 
the crude phospholipids were redissolved in 2 portions of 300 ml each of hex-
ane. The 600 ml extract was concentrated to 200 ml and then rapidly poured 
into 1 liter of cold acetone and allowed to stand until the supernatant 
cleared. After decanting the acetone phase, the precipitated phospholipids 
were washed with cold acetone. This acetone-hexane step was repeated and 
the phospholipids were dried and redissolved in chloroform to give a 10% 
solution. The phospholipid was stored under nitrogen gas at -20°C until 
purification via column chromatography was performed. 
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Purification of the phospholipid was carried out using silicic acid 
columns essentially according to the method of Bingham et al. (89). 
Silicic acid and Hyflo Supercell (2:1) were mixed and washed twice with 
chloroform-methanol (2:1). Residual solvent was removed under vacuum and 
the material was dried in a 120°C oven for several hours. The silicic acid-
Supercell was then dispersed in chloroform-methanol (2:1) and packed in a 
column 2.5 cm x 44 cm with glass wool at the bottom. Lecithin (2.4 g, 
100 g/ml) was applied to the column at a flow rate of 0.7 ml/minute. Elu-
tion of the lecithin was carried out with chloroform-methanol (2:1) with 
periodic monitoring of the fractionation by thin-layer chromatography 
(CHCl3:Me0H:H20:HC00H, 65:25:4:4). The first 175 ml of eluted solvent con-
taining mainly neutral lipids and some phosphatidylcholine was collected. 
The phosphatidylcholine was dried under vacuum and dissolved in chloroform 
in a final concentration of 40 mg/ml. 
B. Buffer System 
Experiments were performed in sodium veronal buffer, pH 7.4, in saline 
containing 0.025% EDTA, unless otherwise specified. 
C. Separation of Lipoproteins from Rabbit Plasma 
Lipoproteins were prepared as described by Lindgren et al. (90) and 
Meusing and Nishida (91). 
Each rabbit was bled via a marginal ear vein and the whole blood was 
collected in citrated centrifuge tubes. The plasma was separated from the 
whole blood and EDTA was added to a final concentration of 0.025%. Sodium 
azide was added at a level of 2.0 mM to prevent bacterial growth. The plasma 
was then centrifuged at 8000 X g for 10 minutes in a SS-35 rotor using a 
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Sorval RC-5 refrigerated centrifuge. Chylomicrons, when present, were re-
moved from the top of the centrifuge tubes by aspiration. The plasma was 
then centrifuged for 24 hours at 37,000 rpm (100,000 x g) in a Ti 50 rotor 
with a Model L3-50 or L2-65B ultracentrifuge (Beckman Instruments, Inc., 
Palo Alto, Calif.). The top VLDL layer was removed by aspiration. A 1-hour 
centrifugation at 37,000 rpm was carried out to remove any remaining chylo-
microns. The VLDL was further purified by repeating the 24-hour centrifuga-
tion. After removing the VLDL, the remaining plasma components were col-
lected through a hole punctured in the bottom of each tube and the fractions 
from pairs of rabbits were pooled. The density of these fractions was in-
creased by the addition of solid sodium bromide to 1.019 g/ml and were again 
centrifuged in a Ti 50 rotor for 48 hours at 37,000 rpm to float the LDLj_ 
(IDL) fraction. The IDL layer was removed by aspiration from the tops of 
the tubes and purified by recentrifugation at the same density. The subna-
tant was collected through a hole pierced in the bottom of each tube. The 
density of this fraction was increased by the addition of solid sodium bro-
mide to 1.063 g/ml followed by centrifugation for 48 hours at 37,000 rpm in 
a Ti 50 rotor. The LDL layer was then removed at the tops of the tubes by 
aspiration. The subnatant was again collected by piercing a hole in the bot-
tom of the tubes. The density of these fractions was adjusted to 1.21 g/ml 
with solid sodium bromide and centrifuged for 48 hours at 37,000 rpm in a 
Ti 50 rotor. After removing the top layer containing the HDL, it was fur-
ther purified by layering the HDL under a sodium bromide solution 
(d = 1.21 g/ml) and centrifugation as previously described. Chemical and 
electrophoretic characterization of each of the lipoprotein classes were 
carried out after dialysis against barbital buffer to remove the salt. 
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D. Phosphorus Determination 
Lipid phosphorus was determined according to the method of Bartlett 
(92) with a modification as described by Parker et al. (93). The samples 
were placed in .chromic acid-washed 10 ml conical centrifuge tubes, 0.25 ml 
of concentrated sulfuric acid was added, and placed in a sand bath heated 
to 250°C for 3 hours. The tubes were removed from the sand bath, allowed 
to cool and 3 drops of 30% hydrogen peroxide were added to each. The tubes 
were then heated for an additional 2 hours at 160°C. After cooling, 5 ml 
of water were added to the digestion mixture along with 0.6 ml of 2.5% 
ammonium molybdate. The contents were then mixed in a Vortex mixer and 
0.24 ml of Fiske-Subba Row reagent was added and the tubes mixed again. The 
tubes were then placed in a boiling water bath, capped with a glass marble, 
and finally cooled to room temperature. 
Colorimetric readings were taken in a Cary recording spectrophotometer 
(Model 11M, Applied Physics Company, Pasadena, Calif.) at 800 nm wavelength 
using quartz cells with a 1 cm light path. 
The phosphorus content of the samples was obtained utilizing standard 
curves prepared from known amounts of potassium dihydrogen phosphate. Phos-
pholipid concentrations were calculated by multiplying the phosphorus con-
tent by a factor of 25.4 which is based on an average molecular weight of 
787 for egg yolk phosphatidylcholine (94). 
E. Protein Determination 
Protein was determined according to the method of Lowry (95). Protein 
samples were diluted to 0.25 ml with water and 0.25 ml of 2N NaOH was added. 
Five ml of a reagent consisting of 49 ml of 2% sodium carbonate, 1 ml of 
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1% sodium potassium tartarate, and 1 ml of 0.5% cupric sulfate were added 
and the contents mixed on a Vortex mixer. The optical density of the sample 
was measured at 750 nm using the Cary recording spectrophotometer 30 minutes 
after the addition of 0.5 ml of the Folin-Ciocalteau reagent previously 
diluted 1:1 with water. Standard curves were constructed for each assay us-
ing bovine serum albumin (Sigma Chemical Company, St. Louis, MO), dried over 
phosphorus pentoxide as the reference protein. 
F. Triglyceride Determination 
Triglycerides were determined according to the Hycel Triglyceride 
Test (Hycel Incorporated, Houston, Texas). Unlike classical methods of de-
termining serum and lipoprotein triglycerides, this method utilizes a fungal 
lipase which specifically hydrolyzes triglycerides to glycerol and free fatty 
acids even in the presence of phospholipid. The glycerol is then measured 
through a series of enzyme reactions (96) coupled in a final step to the 
reduction to a tetrazolium salt forming a colored product easily measured 
colorimetrically. The principal reaction scheme is as followsJ 
After the glycerol was formed via action of fungal lipase from trigly-
ceride, the glycerol was phosphorylated by adenosive triphosphate (ATP) in 
the presence of glycerokinase (GK) to glycerol-1-phosphate (97): 
H2C - OH H2C - OH 
I I 
H - C - OH + ATP GK H - C - OH + ADP 
I l 
H2C - OH H2 - COPO3 
The glycerol-1-phosphate was then dehydrogenated by nicotinamide 
adenine dinucleotide (NAD) to dihydroxyacetone phosphate. This reaction 
is catalyzed by glycerol phosphate dehydrogenase (GDPH) (98) . 
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H2 - COH H2C - OH 
I I 
H - C - OH + NAD GDPH H - C = 0 + NADPH 
l I 
H2 - C - 0 - P03H2 H2C - OP03H2 
The NADH reduces iodonitritetrazolium violet (INT) to its colored formazan 
with phenozene methosulfate (PMS) as a catalyst. 
NADPH + INT — — -• NAD + INT-Formazan 
The INT-Formazan end product was quantitated colorimetrically using the 
Cary recording spectrophotometer at a wavelength of 505 nm. A standard 
curve was constructed for each assay using normal, intermediate and elevated 
reference sera (Hycel Inc., Houston, Texas). When rabbit serum was measured, 
it was used as such. However, the accurate determination of lipoprotein 
triglyceride necessitated that the lipoprotein samples be first dialyzed 
against 0.005M Na veronal buffer, pH 7.4 in saline without EDTA since the 
presence of EDTA may inhibit enzyme activity. The actual procedure used is 
as follows: Samples of from 0.02 to 0.05 ml of serum or lipoproteins were 
pipetted into 1 x 8 cm test tubes and all volumes adjusted with distilled 
water to a total of 0.05 ml. At 20-second Intervals, 0.5 ml of enzyme re-
agent was added. This reagent consisted of 1 part 2,900,000 U fungal lipase, 
150,000 U glycerol phosphate dehydrogenase, and 1780 U glycerokinase to 50 
parts 0.05% magnesium chloride, 8.9 mM adenosine triphosphate and 15.6 mM 
nicotinamide adenine dinucleotide. The tubes were mixed on a Vortex mixer 
and placed in a 37°C water bath. Exactly 10 minutes after the addition of 
the enzyme reagent 0.5 ml of 0.03% iodonitrotetrazolium violet and 0.005% 
phenazine methosulfate was added at 20 second intervals and the tubes were 
again placed in the 37°C bath for exactly 10 minutes. The tubes were then 
diluted with 2.0 ml of 0.1 N hydrochloric acid and cooled to room temperature. 
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The optical density of the samples was measured in the Cary recording spec-
trophotometer at 505 nm within 30 minutes after dilution. A standard curve 
was constructed for each determination using sera of known triglyceride com-
position as the reference lipid. 
G. Cholesterol and Cholesteryl Ester Determination 
Total serum and lipoprotein cholesterol were determined according to a 
method devised by Biodynamics/BMC (Boehringer-Mannheim, Indianapolis, Ind.). 
This procedure is based on the quantitative splitting of all cholesterol es-
ters present in the sample into cholesterol and free fatty acids by the ac-
tion of cholesterol esterase isolated according to Beauchamp et al. (99). 
In the presence of oxygen, free cholesterol is oxidized by cholesterol oxi-
dase (isolated from Nocardia spp. according to Roeschlau et al. (100) to 
cholest-4-en-3-one): 
Cholesterol + 02 . , • Cholest-4-en-3-one + H 20 2 
The hydrogen peroxide formed is used in the presence of catalase (from 
bovine liver - Boehringer-Mannheim, Indianapolis, Ind.) to transform methanol 
into formaldehyde: 
H2o2 + CH3OH
 C a t a l a s e ^ H C O H + 2 H 2 0 
The formaldehyde reacts with ammonium ions and acetyl acetone in the Hantzsch 
(101) reaction to form 3,5-diacetyl-l,4-dihydrolutidine, which can be deter-
mined colorimetrically and is directly proportional to the cholesterol concen-
tration. 
The procedure for the total cholesterol determination was as follows: 
Serum or lipoprotein samples were pipetted into 1 x 10 cm test tubes, 5.0 ml 
of the cholesterol reagent mixture was added and the tubes mixed in a Vortex 
mixer. The cholesterol reagent mixture consisted of 10 parts 1.7 M methanol, 
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and 700 U/ml catalase (EC 1.11.1.6) in 0.6 M ammonium phosphate buffer, 
0.5 parts 0.42 M acetylacetone and 2.1% w/v hydroxypolyethoxydodecase in 
2.5 M methanol and 0.04 parts of 7 U/ml cholesterol esterase (EC 3.1.1.13). 
These tubes were designated as specimen blanks and a second set of specimen 
tubes was labeled. To this second set was added 0.02 ml of 4 U/ml choles-
terol oxidase and 2.5 ml of the material from the specimen blank tubes. 
After thoroughly mixing all tubes, they were placed in a 37°C water bath 
for 1 hour. The tubes were then cooled and the optical density was deter-
mined using the Cary recording spectrophotometer at 410 nm. Cholesterol 
standards (Boehringer-Mannheim, Indianapolis, Ind.) were similarly treated 
and standard curves were constructed for each determination. 
When free cholesterol was determined, the same procedure was carried 
out except for the omission of 0.04 parts of cholesterol esterase from the 
cholesterol reagent mixture. This technique prevented cholesteryl esters 
from being hydrolyzed thereby enabling only free cholesterol to be deter-
mined . 
H. Dietary Regimes for the in Vivo Production of Unique VLDL 
Twenty-four New Zealand white rabbits were bled via the left marginal 
ear vein and assayed for serum triglycerides, cholesterol and cholesteryl 
ester concentration. Twelve of these animals, whose serum lipids were in 
the middle range of values obtained, were maintained on a purina rabbit 
chow pelleted diet for 8-10 weeks and all experiments were performed. Next, 
a semisynthetic diet high in safflower oil (SAFF), was fed and the experi-
ments repeated. After feeding the SAFF diet for 10 weeks, the chow diet 
was again fed for a period of two weeks and serum cholesterol determinations 
were made on each animal. These values were found to be within the normal 
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range as initially determined on the chow diet at this time. Lastly, a 
semisynthetic diet high in hydrogenated coconut oil (COCO) was fed. In 
this way, each animal served as its own control for the 8-10 week period. 
No exogenous dietary cholesterol was put in the last two diets. The com-
position of the individual diets is shown in Table 1. 
Table 1. Composition of Experimental Diets 













iThe two experimental diets contained either 
14% hydrogenated coconut oil, or 14% saf-
flower oil. 
^Amounts in gram/100 lbs. diet: Vitamin A 
(200,000 units/g), 4.5; Vitamin D (400,000 
units/g), 0.25; a-tocopherol acetate, 5.0; 
ascorbic acid, 45.0; inositol, 5.0; choline 
chloride, 75.0; menadione, 2.25; p-amino ben-
zoic acid, 5.0; niacin, 4.5; riboflavin, 1.0; 
pyridoxine hydrochloride, 1.0; thiamine hydro-
chloride, 1.0; calcium pantothenate, 3.0. In 
mg/100 lbs. diet: biotin, 20; folic acid, 
90; Vitamin Bi2, 1-35; D,L-methionine, 100. 
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The composition of the diets was . taken from the catalog or feed tag 
of the commercial suppliers. The diets used were adequate in protein, car-
bohydrate, salt and vitamins (102). It should be noted that the chow diet 
contained a lower caloric density than the coconut or safflower oil diets 
but that the coconut and safflower oil diets were isocaloric with respect 
to one another. The fatty acid composition of the chow, COCO and SAFF 
diets is shown in Table 2. 
The fatty acid composition of the Purina rabbit chow fat showed rela-
tively high amounts of palmitic acid (13.2%), oleic acid (52.8%) and 
linoleic acid (22.3%). 
The hydrogenated coconut oil semisynthetic diet fat contained lauric 
acid (47.3%), myristic acid (20.1%), palmitic acid (10.3%) and stearic 
acid (16.1%) as its major components with octadecenoic acid comprising 
1.6% of the total fatty acid content. 
The safflower oil diet fat contained palmitic acid (7.1%), stearic 
acid (2.7%), oleic acid (12.6%), and linoleic acid (77.0%). No attempts 
were made to characterize the location or isomeric form of the double bonds 
in the linoleic acid fraction. 
I. Collection of Serum and Lipoprotein Lipase-Rich Post-Heparin Plasma 
On the day of bleeding, each rabbit was weighed and placed in an 
animal restraining cage. A small portion of the animal's right ear was 
shaved with a scalpel blade over the area of a marginal ear vein. A nick 
approximately 1 cm in length was made longitudinally along the vein and the 
ear was placed inside a vacuum bleeding apparatus which was maintained at 
about 5-8 mmvHg below atmospheric pressure with a vacuum pump. Two ml of 
0.25 M sodium citrate was used as an anticoagulant. In cases where serum 
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Table 2. Fatty Acid Composition of Dietary 
Lipids 


















































was collected, no anticoagulant was employed and the blood merely allowed 
to clot. Blood samples (40 ml) collected in this fashion were immediately 
placed on crushed ice and centrifuged at 1200 g for 40 minutes in order to 
obtain either serum or plasma. 
When LPL-rich post-heparin plasma (PHP LPL) was to be collected, 100 
units sodium heparin/kg body weight were injected intravenously into a mar-
ginal ear vein of the left ear and blood was collected from a marginal ear 
vein of the right ear after 5 minutes. 
J. Collection of Extra-Hepatic Post-Heparin Plasma 
Twenty-four hours later the same rabbit as above was used as a source 
of LPL-rich plasma of extra-hepatic origin. This plasma was collected and 
prepared essentially by the method of Bezman-Tarcher and Robinson (103). 
Adult New Zealand white rabbits weighing approximately 3.5 kg were preanes-
thetized with 0.02 mg/lb. atropine sulfate (Pitman Moore, Washington Crossing, 
N.J.), given subcutaneously. After 10 minutes, 0.1 mg/lb. acepromazine 
maleate (Ayerst Labs, New York, N.Y.) and 10 mg/lb. ketamine hydrochloride 
(Bristol Labs, Syracuse, N.Y.), were given intramuscularly to induce anes-
thesia. A surgical plane of anesthesia and analgesia was obtained after 
5-8 minutes and a ventral midline incision was made in order to dissect the 
abdominal aorta just proximal to the celiac artery and to place one loose 
ligature of 1/8" umbilical tape around it. Next the post vena cava was dis-
sected distil to the diaphragm and proximal to the liver and another loose 
ligature placed around it. Then a 2-3" section of the inferior vena cava, 
at the level of the left renal vein, was dissected and, using umbilical tape 
and a short length of polyethylene tubing, both the distil and proximal 
parts of the post cava were temporarily ligated, stopping venous flow in 
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the area. A polyethylene cannula was then introduced into this part of the 
inferior vena cava and it was tied in place at the level of the right 
atrium. Heparin solution (100 U/kg body weight) was introduced through 
this cannula and the rabbit was exsanguinated five minutes later through 
the abdominal aorta. Serum collected in this fashion was used for the par-
tial purification of extra-hepatic lipoprotein lipase. 
K. Preparation of Partially Purified LPL (Triacylglycerol Hydrolase) 
The densities of post-heparin plasma, extra-hepatic post-heparin 
plasma, and normal plasma were adjusted to 1.063 and centrifuged at 40,000 
rpm for 36-48 hours in a Beckman Ti-50 rotor in a Beckman L3-50 prepara-
tive ultracentrifuge (Beckman, Inc., Palo Alto, Calif.). This was done 
to disrupt the VLDL-LPL complexes and to remove all lipoproteins of density 
less than 1.063 g/ml. The top layer which contained these lipoproteins was 
removed and discarded. The subnatant was assayed for LPL activity. 
L. Assay of Triacylglycerol Hydrolase (Lipoprotein Lipase) 
1. Preparation of Triglyceride Emulsions and Assay 
Artificial substrate emulsions for the assay and characterization of 
rabbit triacylglycerol lipases were prepared essentially according to the 
method of Nilsson-Ehle et al. (104). Radio-labeled H^-triolein and un-
labeled triolein were mixed to give 100 mg of triolein with about 1.36 x 10^ 
cpm and 6.0 mg of egg phosphatidyl choline was added. After evaporating the 
solvent under a stream of nitrogen gas, the dried lipids were emulsified 
in 1.0 ml (1.25 g) of glycerol by homogenization for 5 minutes using a 
Branson Model J-18A Sonicator equipped with a micro-probe (Branson Sonic 
Power Co., Danbury, Conn.). 
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The homogenization was carried out in a glass screw-capped vial, 
1 x 6 cm, immersed in an ice bath. The emulsion is optically clear and 
could be stored at 20°C with no auto-hydrolysis of triglyceride for up to 
about 6 weeks (as determined by thin-layer chromatography). 
Substrate solutions for assay were prepared fresh as needed by com-
bining 0.2 ml of the concentrated substrate emulsion described above with 
0.8 ml 0.005 M sodium barbital buffer, pH 7.4 containing 3% bovine serum 
albumin and 0.2 ml of normal rabbit serum. This mixture was vigorously 
shaken on a vortex mixer for 30 seconds and yielded an opaque emulsion 
ready for use. Incubations were carried out in 10 ml screw-capped conical 
centrifuge tubes at 37°C in a total volume of 0.2 ml with 0.09 ml of sub-
strate, 0.01-0.06 ml of enzyme preparation, and 0.05-.10 ml 5 mM sodium 
barbital buffer in saline, pH 7.4. Other conditions are as indicated in 
Results. The final concentration in the assay tubes were triolein, 
6.1 ymoles/ml; lecithin, .51 umole/ml; albumin, 1% (w/v); and serum, 9% 
(v/v); in 5 mM sodium barbital buffer, pH 7.4 in saline. Assay time was 
typically 1 hour. 
The fatty acid produced during the incubation period was isolated via 
a modification of the liquid-liquid partition system described by Belfrage 
and Vaughan (105). The reaction was stopped by adding 3.3 ml of methanol: 
chloroform:heptane (1.41:1.25:1) v/v/v, followed by 1.0 ml of 0.1 potassium 
carbonate-borate buffer, pH 10.5. The extraction and all other subsequent 
procedures were performed at room temperature. After thoroughly mixing 
each tube in a vortex mixer for 15 seconds, the tubes were centrifuged for 
25 minutes at 1100 x g. A 1.0 ml aliquot of the methanol-water upper phase 
(total volume of upper phase 2.4 ml) was counted in a Packard Tri-Carb 
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Liquid Scintillation Spectrometer using 10 ml of Aquasol (New England 
o 
Nuclear, Boston, Mass.). This upper phase contained about 76% of the H -
oleic acid released. An aliquot (10 ul) of the assay substrate was assayed 
for radioactivity after the addition of 1 ml of upper phase from control 
incubations without enzyme. 
2. Acetone Injection Method for Radio-Labeling of VLDL-Triglyceride 
The desired amount of H3-9,10 triolein was dissolved in 10-15 yl of 
acetone. The labeled triolein was then slowly injected into 1.0 ml of 
rapidly stirring VLDL in 5 mM sodium barbital buffer, pH 7.4, under a steady 
stream of nitrogen gas which helped remove the acetone. Next 50 mg of bo-
vine serum albumin per ml of VLDL was added, the mixture was equilibrated 
for 12 hours at 4°C and then centrifuged for 30 minutes at 37,000 rpm in 
a 40.3 rotor to remove non-incorporated aggregates. 
3. Assay with Natural Substrate 
One microliter of the enzyme preparation to be measured was added to 
80 yl of radio-labeled VLDL (3.00 mg triglyceride/ml) in 5 mM sodium bar-
bital buffer, pH 7.4, in saline to a final assay volume of 0.2 ml (final 
assay concentrations were 1.2 mg triglyceride/ml, 5 mM sodium barbital 
in 0.9% NaCl, pH 7.4, and approximately 50-70 mUnits/ml lipase activity 
as determined under artificial substrate assay conditions). The assay was 
performed at 37°C for 30 minutes as the fatty acids released were extracted 
and counted in a Packard Tri-Carb Scintillation Spectrometer as described 
above for the artificial substrate assay method. 
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M. The Selective Measurement of Extra-Hepatic Triacylglycerol Hydrolase 
Activities 
After the intravenous injection of sodium heparin, it is possible to 
measure, in plasma, the activities of 2 different triacylglycerol hydro-
lases: lipoprotein lipase released from peripheral tissues and hepatic 
lipase. These activities were measured according to the method of Krauss 
et al. (53) which takes advantage of the selective inhibition of the peri-
pheral enzyme activity in the presence of protamine sulfate. 
Typically, 10 yl aliquots of PHP LPL were preincubated with from 0.2 
to 7.2 mg protamine sulfate/ml final assay mixture for 10 minutes at 27°C. 
Next, 60 yl of the radio-labeled artificial substrate emulsion was added 
in a final concentration of 3 mg triolein/ml assay mixture and the tubes 
were incubated at 37°C for 1 hour. The free fatty acids released were then 
extracted (see Assay of LPL in Materials and Methods section) and counted 
in the Packard Tri-Carb Scintillation Spectrometer. Results of this ex-
periment provided a measure of the protamine resistant triacylglycerol 
hydrolase activity in the PHP LPL preparation. 
Similarly, aliquots of PHP LPL were pre-incubated in 5 mM barbital 
buffer for 10 minutes at 27°C, then assayed for lipase activity in order 
to measure the total triacylglycerol hydrolase activity. Protamine sen-
sitive lipase activity was then measured by subtraction of the two values 
obtained. 
N. Agarose Electrophoresis of Lipoproteins 
Agarose gel electrophoresis of lipoproteins or sera was carried out 
utilizing the ACI Cassette Electrophoresis Cell and power supply having a 
constant output of 90V (Corning Medical, Palo Alto, Calif.). Agarose 
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Universal electrophoresis film (Analytical Chemists, Inc., Palo Alto, 
Calif.) was used, which are pre-cast gels consisting of 1.0% agarose, 5% 
sucrose and 0.035% disodium EDTA in 0.065 M barbital buffer, pH 8.6. Lipo-
protein or serum samples of 1.0 to 3.0 yl were applied to the sample wells 
in the gel and allowed to evaporate at room temperature. Next the agarose 
film was placed into the cassette cover and placed on the cell which was 
filled with 0.05 M barbital buffer, pH 8.6, containing 0.035% EDTA. The 
samples were allowed to migrate for 30 minutes. 
After electrophoresis, the agarose film was heat-dried in a 75°C 
oven to fix the lipoprotein. The lipoproteins were then stained 
with 0.02% fat Red 7B, clearing and rinsing the film sequentially in 
MeOH:H20 (1:1 v/v) and 2% glycerol or in 10% acetic acid. The gels were 
then quantitated densitrometrically on a Gelman ACD 15 Model 39430 Scanning 
Densitometer (Gelman Instrument Co., Ann Arbor, Mich.) at 575 nm. 
0. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis was carried out using a Bio-Rad 
Model 220-vertical slab gel electrophoresis cell (Bio-Rad Laboratories, 
Richmond, Calif.). Separating gels, 14% in acrylamide, were cast between 
14 x 17 cm glass plates containing 0.1% sodium dodecyl sulfate in 1.5 M 
tris HCl buffer, pH 8.4, using 0.05% ammonium persulfate as a polymerizing 
agent. A stacking gel consisting of 5% acylamide was next cast using the 
plastic comb provided by Bio-Rad for the purpose of making sample wells 
at the top of the vertical slab. Samples were prepared by mixing equal 
volume amounts of from 10-60 yg lipoprotein with a solution containing 
20 ml 10% SDS, 5 ml mercaptoethanol, 10 mg glycerol and 12.5 ml of 0.5 M 
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tris HCl buffer pH 6.8 to which 0.01% Bromphenol blue was added. This 
mixture was then heated for 10 minutes at 100°C in order to solubilize the 
apoproteins of the specific lipoprotein used. 
The apoproteins were electrophoretically separated at a constant 
current of 9 mA for 3-4 hours or until the Bromphenol blue tracking dye was 
1.0 cm from the bottom of the slab. 
Gels were removed from between the glass plates and stained overnight 
in 0.025% Coomassie blue in isopropanol:H20:acetic acid (25:65:10) and de-
stained for 12 hours in 10% acetic acid. The gels were then sealed in 10% 
acetic acid in optically clear plastic film using a Dazey Seal-a-Meal Model 
SAM 1 (Dazey Products Co., Industrial Airport, Kans.), and stored until den-
sitometric tracings could be accomplished. Scans were conducted with the 
Gelman Densitometer at 675 nm. 
P. Preparation of VLDL Remnant Lipoproteins 
After enzyme preparations, NPLAS, PHP LPL, and EHP LPL were isolated 
(d > 1.063 g/ml), VLDL which contained 0.9 mg triglyceride/ml VLDL was in-
cubated in rotor Ti 50 cellulose nitrate tubes with these enzyme preparations 
containing lipase activity of approximately 17.5 ymoles free fatty acid re-
leased/hour for 4 hours, in 0.005 M sodium barbital buffer, pH 7.4 in saline. 
The incubation was stopped by adding enough NaCl of density 1.1923 g/ml to 
adjust the media to a density of 1.019 g/ml. The tubes were centrifuged at 
48,000 rpm in a Ti 50 rotor for 24 hours. The supernatant resulting from 
this centrifugation was designated VLDL remnants and was further purified 
by recentrifugation in the Ti 50 rotor at 48,000 rpm for 48 hours in a 
Beckman L3-50 or L2-65B preparative ultracentrifuge. 
33 
Q. Total Lipid Extraction of Serum Lipoproteins 
To tubes containing 0.1 ml of lipoprotein (ca 3-5 mg/ml), 2.0 ml of 
CHCl3:MeOH 2:1 with 0.2 yl acetic acid per 100 ml were added. The tubes 
were shaken on a mechanical shaker for 15 minutes, heated in a 60°C water 
bath for 15 minutes and again shaken for 15 minutes. After centrifugation 
at 2500 rpm in a clinical centrifuge for 5 minutes, 0.5 ml H20 was added 
and the tubes were again shaken and centrifuged for 15 minutes each and 
the aqueous phase was removed and discarded. The organic phase containing 
the lipid was dried under a steady stream of nitrogen gas and 10 yl of 
CHCl3:MeOH (2:1, v/v) was added to each tube. 
R. Thin-Layer Chromatography of Lipoprotein Lipids 
Major lipid classes were fractionated via thin-layer chromatography 
using silica gel G coated glass plates, 20 x 20 cm, which had been activated 
for 1 hour at 110°C. After applying the lipid samples and appropriate stan-
dard lipids under a stream of nitrogen gas to the plates, they were devel-
oped in hexane:ether:acetic acid 90:10:1. The solvent was allowed to dis-
sipate in a specially constructed plexiglass box which allowed a constant 
flow of nitrogen gas across the plate in order to protect the lipid from 
oxidation. Next the fractionated lipids were briefly visualized under io-
dine vapor, the spots outlined using a clean dissecting needle, and the 
plate returned to the nitrogen gas flow box to get rid of any residual io-
dine. The spots were then scraped off the plates and placed in 1.5 x 13 cm 
screw-capped test tubes fitted with teflon liners. 
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S. Preparation of Fatty Acid Methyl Esters of Lipid Classes 
To the tubes from the above procedure (containing fractionated lipid 
classes and silica gel) 2 ml of 4% sulfuric acid in methanol were added. 
The tubes were then heated for 60 minutes on a steam cone. After cooling, 
2 ml of distilled water were added, and the methyl esters of the fatty 
acids were extracted by three separate additions of 2 ml hexane, the con-
tents mixed on a vortex mixer and the upper layer was pooled. Residual 
water was removed from the hexane phase by addition of solid anhydrous so-
dium sulfite. Controls of reagents and silica gel from developed plates 
were routinely run simultaneously with lipid samples. 
T. Analysis of Fatty Acyl Composition of Lipid Classes by Gas-Liquid 
Chromatography 
The methyl esters in hexane were concentrated under a stream of nitro-
gen gas for analysis by gas-liquid chromatography. Fatty acid compositional 
analysis was performed on a 6' x 1/8" stainless steel column, packed with 
10% SP2330 on 100/120 Chromosorb W AW (Supelco, Inc., Bellefonte, Penn.). 
Fatty acids were identified by GLC analysis of commercially available 
methyl esters of fatty acid standards by equating retention times. 
U. Gas-Liquid Chromatography Operation Conditions 
The analysis of methyl esters of fatty acids from phospholipid, tri-
glycerides and cholesteryl esters was performed on a Hewlett Packard Re-
search Gas Chromatography Model 5750 equipped with a dual flame ionization 
detector. The injection port heater and the flame ionization detector 
heater were maintained at 250°C and 290°C respectively. The operating 
conditions consisted of 30 ml/minute helium carrier gas flow rate measured 
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at the column outlet, with 30 ml/minute hydrogen gas flow rate, and 250 ml/ 
minute air flow rate. Column oven temperature was maintained at 190°C and 
injections were performed directly into the column. The chromatograph 
electrometer was interfaced with a Hewlett Packard Digital Integrator Model 
3380A which produces a chromatogram and determines the retention times of 
peaks, peak area and percentage of each peak area of the total. The in-
tegrator was started simultaneously with sample injection. Throughout the 
analysis, the chromatograph electrometer was operated at range 100 and at-
tenuation 2. 
V. Source of Chemicals 
Triolein (>99.5% pure) and methyl ester standards for gas-liquid 
chromatography were purchased from NuChek Prep, Inc., Elysian, Minnesota. 
Glycerol tri (9,10(n)-H3) oleate, (H^-triolein), 50 mCi/mmole was supplied 
by Amersham Corporation, Arlington Heights, Illinois. Pre-cast 1% agarose 
slab gels were purchased from ACl/Corning, Palo Alto, California, and all 
polyacrylamide gel reagents were obtained from Bio-Rad Laboratories, 
Richmond, California. Safflower oil for the diets was purchased from a 
local supplier, manufactured by Hain Pure Food Company, Los Angeles, Cal-
ifornia, while the hydrogenated coconut oil was obtained from Drew and Com-
pany, New Jersey. Casein was purchased from Erie Casein Company, Erie, 
Illinois, and Salt Mixture XIV and the Vitamin Diet Fortification Mixture 
were obtained from the Nutritional Biochemicals Division of ICN Life Sci-
ence Group, Cleveland, Ohio. Additionally, after the diets were mixed, 
they were pelleted by the ICN Life Science Group, Cleveland, Ohio. Pro-
tamine sulfate (from salmon, grade 1) and bovine serum albumin, essentially 
fatty acid free were purchased from Sigma Chemical Company, St. Louis, 
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Missouri, while sodium heparin (100 units/mg) was obtained from Nutritional 
Biochemicals, Cleveland, Ohio. The triglyceride test set was supplied 
(Hycel #961) by Fischer Scientific Company, Itasca, Illinois. The choles-
terol reagent test set was obtained from Bio-dynamics Division of 
Boehringer-Mannheim, Indianapolis, Indiana. All other chemicals and rea-
gents were supplied by Fischer Scientific Company, Fairtown, New Jersey, 
or Mallinckrodt Chemical Works, St. Louis, Missouri. 
III. RESULTS 
Section I 
A. Adequacy of the Dietary Fatty Acids 
To assure that the hypercholesterolemia and altered VLDL produced by 
the COCO diet was not secondary to essential fatty acid deficiency, the 
fatty acid composition of the lipoprotein phospholipids were analyzed. 
Holman has found that a triene:tetraene (20:3u)9:20:4(o6) ratio greater than 
0.4 is seen in EFA-deficient rats (106). Likewise a ratio of oleic acid to 
linoleic acid greater than 1.5 is indicative of EFA deficiency in the phos-
pholipid fraction of guinea pig erythrocytes (107). None of the VLDL phos-
pholipids of rabbits analyzed had a triene:tetraene ratio greater than 
0.28 or an oleic acid:linoleic acid greater than 1.13. There was some 
weight loss in a few of the animals during the first ten days on both the 
COCO and SAFF diets but the weight was regained by the end of the third 
week. By these criteria, then, the stores of EFA in these adult animals 
was adequate to protect them from any deficiency over the course of the 
feeding study employed. 
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B. Serum Lipid and Lipoprotein Profiles: Variation with Diet 
1. Serum Lipid Concentration 
The effect of the diets on serum triglyceride, total cholesterol, and 
free and esterified cholesterol levels is seen in Table 3. The cholesterol 
free, high fat semisynthetic diets produce a marked cholesterolemia in the 
rabbits fed these diets for 9 weeks. The SAFF diet-fed animals' serum 
cholesterol values were also elevated when compared to the chow-fed case, 
but the differences here were not as statistically significant as when the 
COCO diet was fed. Serum triglyceride levels in the animals were rela-
tively unchanged except in the SAFF case where a slight decrease in the 
triglyceride concentration was observed. Additionally, the serum of the 
rabbits after feeding the COCO diet was noticeably lipemic. 
2. Plasma Lipoprotein Concentration 
Rabbits fed both experimental diets showed elevated concentrations 
of VLDL (Table 4), especially in the case of the COCO diet. With respect 
to the LDL concentration (LDL^ + LDL2), the COCO diet yielded an increased 
amount of this fraction while the SAFF diet resulted in a somewhat lower 
concentration as compared to the chow-fed case. HDL values, while not too 
significantly different among the three dietary treatments, showed a de-
creasing trend in the experimental groups, with the COCO-fed rabbit HDL 
having the lowest HDL concentration. The most significant finding is that 
when the experimental diets are fed, an increase in concentration of serum 
lipoproteins with d < 1.063 g/ml occurs. In the COCO diet-fed case, more 
than 93% of the serum lipoproteins exist in this d < 1.063 g/ml fraction. 
Serum lipoproteins from SAFF- and chow-fed animals are more similar to 
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Table 3. Serum Triglyceride (TG), Total Cholesterol (TC), 
Free Cholesterol (FC), and Cholesteryl Ester (CE) 
of Rabbits after 9 Weeks on Different Diets 
(mg/dl+S.E.M.) 
Diet TG FC CE* TC 
SAFF (n=10) 67+7a 50+8* 218+23^ 178+223 
COCO (n=10) 113+20 135+17b>d 537+55b»e 451+42C»e 
Chow (n=9) 104+10 30+2 151+11 119+8 
aSignificantly different from chow @ p < .05 level 
^Significantly different from chow @ p < .01 level 
cSignificantly different from chow @ p < .001 level 
dSigmf icantly different from SAFF @ p < .05 level 
eSignificantly different from SAFF @ p < .01 level 
Cholesteryl ester deterlmined as free cholesterol, but ex-
pressed as cholesteryl oleate 
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Table 4. Concentration of Serum Lipoproteins in Response to 
Different Diets (mg/dl) 
VLDL LDLi LDL2 HDL LDL 
Diet n=10 n=5 n=5 n=5 HDL Total 
SAFF 40+9a 12+lc 39+3 24+2 2.1 115 
COCO 144+5b>d 4+0.7 120+5d 20+2e 6.2 288 
Chow 15+1 n/d 85+2 27+2 3.1 127 
aSignificantly different from chow @ p < .01 level 
bSignificantly different from chow @ p < .001 level 
csignificantly different from COCO @ p < .01 level 
dSignificantly different from SAFF @ p < .001 level 
eSignificantly different from chow @ p < .05 level 
n/d - Not determined 
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one another in terms of distribution of density fractions. The LDL to 
HDL ratio, which has been used as a measure of atherogenicity, is also 
included in Table 4 and in the case of the COCO-fed rabbits is appreciably 
elevated when compared to the two other dietary treatments. 
3. Summary of Lipoprotein Alterations 
Five major changes are consistently observed in the serum lipoproteins 
after cholesterol feeding (see Literature Review). Table 5 summarizes the 
results of feeding the two semisynthetic diets on these five parameters 
and compares them with the cholesterol-induced hypercholesterolemia case. 
In addition to the hypercholesterolemia seen in rabbits fed the COCO diet, 
only four of these five major changes occurred. The presence of B-VLDL 
as well as increases in IDL and LDL and a decrease in the typical HDL were 
observed which are similar to the result reported in cholesterol-induced 
hyperlipoproteinemia (60). No detectible amount of HDLC was found to be 
present, however. 
In the SAFF-fed case, on the other hand, while an increase in serum 
cholesterol and IDL and a decrease in typical HDL were observed, no B-VLDL 
or HDLC were noted, and LDL decreased somewhat. 
C. Chemical Composition of Serum Lipoproteins: Variation with Diet 
1. VLDL 
Figure 1 shows the chemical composition of the rabbit serum VLDL from 
each dietary group. In the experimental diets, the rabbit VLDL was changed 
from triglyceride-rich to cholesteryl ester enriched particles. The tri-
glyceride-rich VLDL (59.7%) from chow-fed rabbits averaged 11.9% protein, 
18.8% phospholipid, 3.1% free cholesterol and 8.2% cholesteryl ester. The 
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Table 5. The Effect of High Saturated or Unsaturated Fat Diets 
1 
and High Cholesterol Supplementation on the Serum 
Lipoprotein Profile: Comparison of Dietary Treatments 
Dietary Treatment 
Cholesterol 





















B-VLDL refers to that lipoprotein with d < 1.006 g/ml and with 
g-mobility on agarose or paper electrophoresis 
HDLC refers to that lipoprotein which has characteristics in 
common with both LDL and the typical HDL 
HDL2 refers to that lipoprotein regarded as typical HDL 
^From Disturbances in Lipid and Lipoprotein Metabolism, 1978, 
eds. J.M. Dietschy, A.M. Gotto, Jr., J.A. Ontoko, Baltimore: 
Waverly, p. 188. 
+ refers to increased serum concentration 
4- refers to decreased serum concentration 
yes/no refers to presence or absence of this lipoprotein 
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Figure 1. Relative chemical composition of rabbit serum VLDL from each 
dietary group. The abbreviations used are as follows: SAFF, 
semisynthetic rabbit diet containing 14% safflower oil; COCO, 
semisynthetic rabbit diet containing 14% hydrogenated coconut 
oil; chow, normal chow diet; TG, triglyceride; PL, phospho-
lipid; P, protein; FC, free cholesterol; EC, esterified cho-
lesterol. Standard errors are indicated for n = 10. 
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cholesteryl ester enriched VLDL from COCO-fed animals contained only 
22.5% triglyceride, 5.4% protein, 21.2% phospholipid, 10.8% cholesterol 
and 40.1% cholesteryl ester. The chemical composition of VLDL from ani-
mals fed the SAFF diet were in between the two other groups in terms of 
triglyceride, protein and cholesterol content with 33.3% triglyceride oc-
curring along with 7.7% protein, 18.8% phospholipid, 11.0% free cholesterol 
and 29.2% esterified cholesterol. Phospholipid values did not differ 
markedly between the three groups, yet the protein to lipid ratios of chow, 
COCO, and SAFF diet-fed rabbits were 0.10, 0.06 and 0.08 respectively. In 
addition, the surface to core ratio (P + PL + C/TG + CE) were .50, .60, and 
.60 for chow, COCO, and SAFF diet-fed animals respectively. 
2. LDLi (IDL) 
Figure 2 shows the composition of the rabbit serum LDL]_ (IDL) found 
after the feeding of the two experimental diets used. In the case of the 
COCO-fed animals, more triglyceride and cholesteryl esters are carried in 
this intermediate density fraction (1.006 < d < 1.019 g/ml). SAFF diet-
fed rabbit IDL contained 13.4% triglyceride, and 27.8% cholesteryl ester 
with 13.9% protein, 27.8% phospholipid, and 17.1% free cholesterol. In 
the animals fed the COCO diet, it was found that the IDL fraction was made 
up of 22.6% triglyceride and 39.8% cholesteryl ester with surface constitu-
ents in the following proportions: 7.3% protein, 21.2% phospholipid and 
9.1% free cholesterol. The sum of the core components (i.e., triglyceride 
and cholesteryl esters) from the COCO diet-fed rabbit IDL indicates that 
this dietary regimen yielded an intermediate density particle which is 
perhaps larger than its SAFF diet counterpart. That is, the contribution 
of core constituents in the case of IDL from the COCO diet-fed rabbit is 
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Figure 2. Relative chemical composition of rabbit serum IDL (LDLj) from 
each dietary group. The abbreviations used are as described 
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much greater than in the SAFF diet-fed case. Surface to core ratios also 
are consistent with this idea with the COCO and SAFF IDLs having values 
of 0.6 and 1.4 respectively. 
3. LDL2 
The chemical composition of rabbit serum LDL2 (1.019 < d < 1.063 g/ml) 
from the animals fed the various diets is indicated in Figure 3. The values 
obtained were as follows: SAFF diet LDL„: triglyceride, 9.6%, cholesteryl 
ester, 17.7%, with 18.9% protein, 32.1% phospholipid, and 21.6% free choles-
terol; COCO diet LDL£: triglyceride, 9.2%, cholesteryl ester, 7.2%, with 
25.6% protein, 44.1% phospholipid and 14.0% free cholesterol; chow diet 
LDL2: triglyceride, 12.7%, cholesteryl ester, 24.6% with 33.5% protein, 
23.5% phospholipid and 6.3% free cholesterol. Figure 3 also shows that 
there is a large significant increase in the relative amount of phospho-
lipid and free cholesterol in the case of the experimental diet serum LDL2 
as compared to the chow-fed LDL2 case. Surface to core ratios for LDL2 
from each of the three dietary treatments are 2.7, 5.1, and 1.7 for the 
SAFF, COCO, and chow-fed animals' LDL2 respectively, indicating a quite 
small particle in the COCO case as compared to the LDL2 for the other two 
dietary treatments. 
4. HDL 
The composition of HDL fractions (1.063 < d < 1.21 g/ml) of animals 
fed the various diets are found in Figure 4. Chow-fed rabbits contained 
7.2% triglyceride, 3.1% cholesteryl ester along with 47.2% protein, 30.9% 
phospholipid and 3.1% free cholesterol in the HDL. In the SAFF diet-fed 
animal, triglyceride comprised 2.1%, cholesteryl ester, 26.5%, protein, 
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Figure 3. Relative chemical composition of rabbit serum LDL (LDL2) from 
each dietary group. The abbreviations used are as described 
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Figure 4. Relative chemical composition of rabbit serum HDL from each 
dietary group. The abbreviations used are as described in 
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37.5%, phospholipid, 30.9% and free cholesterol, 3.1%. The COCO-fed case 
yielded HDL of the following composition: triglyceride, 6.3%, cholesteryl 
ester 18.5% with 37.8% protein, 31.7% phospholipid, and 5.6% free choles-
terol. This fraction appears to be preferentially enriched in cholesteryl 
esters at the expense of a decrease in free cholesterol, triglyceride and 
protein. Surface to core ratios for this fraction are 2.5 for the SAFF-HDL, 
3.0 for the C0C0-HDL, and 8.7 for the chow-HDL, indicating that the HDL 
from experimental diets are much larger particles when compared to the 
chow case. This finding is consistent with an HDL particle relatively 
enriched in its core cholesteryl ester component and is in agreement with 
the concept that HDL may be attempting to protect against cellular choles-
terol accumulation. 
D. Electron Microscopy of VLDL 
Electron microscopy of the isolated VLDL was performed in order to 
check the heterogeneity and mean particle size of the VLDL preparations. 
Figure 5 shows the distribution of VLDL sizes typically found. The chow-
fed VLDL had a mean diameter of 365 A. This finding is consistent with 
previously reported VLDL sizes (108) and was used to assess the presence 
of VLDL in the d < 1.006 g/ml fraction isolated by ultracentrifugation. 
E. Agarose Gel Electrophoresis of Serum Lipoproteins: Variation with Diet 
The results of typical densitometric scans of serum after agarose 
electrophoresis from rabbits fed the various diets, stained with fat red 
7B, are seen in Figure 6. Serum from rabbits fed chow or SAFF diets yielded 
the normal pattern of beta, pre-beta, and alpha lipoproteins. However, when 
the COCO diet was fed, electrophoresis of the serum lipoproteins showed the 
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Figure 6. Densitometric scans of serum after agarose electrophoresis from 
rabbits fed the various diets. The gels were stained with fat 
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absence of the pre-beta lipoprotein fraction normally present. Lipopro-
teins of pre-beta mobility on agarose gels correspond to the VLDL (d < 1.006 
g/ml) from normal serum. Because of this finding, VLDL and LDL from rabbits 
after each dietary treatment were isolated and agarose gel electrophoresis 
was performed. Figures 7, 8 and 9 show the relative mobilities of the VLDL 
(d < 1.006 g/ml) and LDL (1.019 < d < 1.063 g/ml) isolated from rabbits fed 
the various diets. In the case of lipoproteins from rabbits fed either the 
chow or the SAFF diet (Figures 7 and 8) the d < 1.006 g/ml lipoprotein re-
mained pre-beta in its mobility on agarose, and the 1.006 g/ml < d < 1.063 
g/ml fraction had beta mobility. When agarose electrophoresis was per-
formed on the isolated lipoproteins from the COCO diet-fed animals, however, 
both the VLDL and LDL were of g-mobility (Figure 9). This alteration in 
electrophoretic behavior points out that some change in the net charge of 
the VLDL particle has occurred (possibly in its protein moiety). Results 
similar to these found in the COCO diet case have been reported in the VLDL 
of rabbits made cholesterolemic via supplementary cholesterol feeding (78) 
indicating a possible similar relationship between the altered VLDL from 
these two dietary cases. VLDL which floats at d < 1.006 g/ml and is beta 
in its agarose mobility has been termed B-VLDL. 
The possibility exists that there may be 0-migrating VLDL (B-VLDL) in 
the serum of rabbits fed the SAFF diet as well as the normal pre-beta VLDL. 
Yet when the d < 1.006 g/ml fraction was isolated from serum of rabbits fed 
the SAFF diet and their electrophoretic mobilities determined, only one 
band, with normal pre-£ mobility was seen. Consequently, the altered 
B-VLDL seen in animals fed the COCO diet must somehow be related to the 
high saturated fat content and not merely to the high total fat content of 
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Figure 7. Densitometric scans of serum VLDL and LDL after agarose electro-
phoresis from rabbits fed the chow diet indicating their rela-
tive mobilities (pre-beta and beta). Conditions were as de-
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Figure 8. Densitometric scans of serum VLDL and LDL after agarose elec-
trophoresis from rabbits fed the SAFF diet indicating their 
relative mobilities (pre-beta and beta). Conditions were as 
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Figure 9. Densitometric scans of serum VLDL and LDL after agarose elec-
trophoresis from rabbits fed the COCO diet indicating their 
relative mobilities (both were beta). Conditions were as 
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this diet. (The SAFF diet is as high in total fat as the COCO diet but 
highly polyunsaturated.) 
The electrophoretic mobility of the LDLi (or IDL, 1.006 < d < 1.019 
g/ml) from rabbits fed either the SAFF or COCO diet were in the beta range 
with no distinct differences among the groups. HDL as well consistently 
migrated with oc-mobility whether isolated from rabbits fed either of the 
dietary treatments employed. 
F. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis of Rabbit 
Serum Apolipoproteins: Variation with Diet 
Associated with the changes in agarose electrophoretic mobility and 
chemical composition of the rabbit VLDL was an alteration in the apolipo-
protein composition among the dietary treatments. While changes in the 
mobility of apo LDL (apo B) and apo HDL (apo A) did not occur, one partic-
ular apo VLDL peptide was markedly increased with respect to the other 
apo VLDL peptides normally present. Figure 10 shows the densitometric 
scans of apo VLDL peptides after SDS-polyacrylamide gel electrophoresis 
and Coomassie blue staining. Zone 1 of Figure 10 corresponds to the apo 
B peptide which is quite polymorphic while Zones 2 and 4 represent the 
apo C peptides. Zone 3 corresponds to the arginine-rich peptide (apo E) 
component of VLDL. These zones were assigned to include the respective 
peptides mentioned based on the typical behavior of rabbit apo VLDL in 
14% SDS-polyacrylamide gels after comparisons of the mobilities of apo 
LDL, apo VLDL and apo HDL peptides on similar gels. 
Table 6 shows the apolipoprotein composition of VLDL from rabbits 
fed the various diets. Chow-fed rabbit VLDL contained 60% apo B and 32% 
apo C peptides with only about 8% of the apolipoprotein made up of the 
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Figure 10. Densitometric scans of apo VLDL peptides after sodium 
dodecyl sulfate polyacrylamide gel electrophoresis from 
rabbits fed the various diets. The gels were stained with 
Coomassie blue and the scans were performed at 675 nm. 
The abbreviations used were as indicated in Figure 1. 
Zones 1, 2, 3 and 4 are described in the text, page 64. 
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Table 6. Apo-VLDL % Composition of Rabbits on 
Different Diets 
Zone 1 Zone 3 Zones 2 & 4 
Diet (Apo-B) (Arg-Rich) (Apo-C) 
Chow 60 (1.1)* 8 (0.1) 32 (0.6) 
SAFF 58 (1.9) 17 (0.5) 25 (0.8) 
COCO 45 (3.3) 39 (2.8) 16 (1.2) 
^Figures in parentheses represent mg VLDL protein/dl 
serum 
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arginine-rich peptide. Apo VLDL from rabbits fed the SAFF diet, while 
containing a similar relative amount of apo B (58%), was made up of 25% 
apo C peptide and more than twice as much of the arginine-rich peptide (17%) 
as the chow-fed rabbit VLDL. In the case of the COCO diet-fed rabbits, 
the serum VLDL apoproteins contained only 45% apo B while the apo C pep-
tides decreased by half to 16%. Additionally the arginine-rich peptide 
accounted for nearly 40% of the total VLDL apoprotein composition, almost 
a five-fold increase, when compared to the chow case. Furthermore, in-
creases in the absolute amounts of all apo peptides were noted in the case 
of the experimental diets. This finding is consistent with the increased 
amount of VLDL seen in rabbits fed the experimental diets. In summary, 
then, not only was there an increase in the relative and absolute amounts 
of the arginine-rich peptide in apo VLDL after feeding the COCO diet, but 
also a decrease in the contribution of the apo C peptides to the total apo 
VLDL. A similar finding was also observed, but to a lesser extent, after 
the feeding of the SAFF diet to the rabbits. This result may be respon-
sible for the decreased mobility of the VLDL in agarose gels in that the 
increased amount of the arginine-rich peptide, a positively charged spe-
cies at the pH employed, migrates less toward the anode during the applica-
tion of the electrophoretic potential than normal VLDL, which is less posi-
tively charged. 
G. Fatty Acid Composition of Lipid Classes of Rabbit Serum Lipoproteins: 
Variation with Diet 
As expected, the serum lipoprotein fatty acid compositions reflect 
the type of dietary fat supplied to the rabbits. In the chow-fed case 
(Table 7), the fatty acids most prevalent in the diet (16:0, 18:1 and 18:2) 
Table 7. Fatty Acid Composition (Mean % + S.E.) of Lipid Classes of Plasma Lipoproteins in Rabbits Fed 















































































































*Substantially different from stearic acid content of chow diet fed 
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were also most prevalent in the triglyceride, phospholipid and cholesteryl 
ester of all lipoprotein fractions. The only exception was that nearly 
20% of the phospholipid moiety of VLDL, LDL and HDL consisted of stearic 
acid (18:0) which may have resulted via chain elongation of shorter-chain 
saturated fatty acids, deacylation-reacylation or perhaps de novo synthesis 
of fatty acids. This increase in relative amount of stearic acid appeared 
to have been at the expense of oleic acid which is somewhat reduced when 
compared to the amount of oleic acid in the fat of the chow diet. 
The fatty acid compositions of lipoprotein lipids after feeding the 
animals either the SAFF or COCO diet are shown in Tables 8, 9, 10 and 11. 
The large difference in the saturation level of these two diets was re-
flected in the fatty acid composition of the lipoprotein lipids (triglycer-
ides, cholesteryl esters, and phospholipids). The greatest differences 
were found in the palmitate (16:0), oleate (18:1) and linoleate (18:2) 
content of the three lipid classes. In general, the percentages of pal-
mitate and oleate were significantly decreased during feeding of the poly-
unsaturated fat diet (SAFF diet) while linoleate was consistently in-
creased in each lipid class after the feeding of this diet when compared 
to the COCO case. Also the fatty acid composition of the lipoprotein tri-
glycerides and cholesteryl esters were most affected by SAFF diet feeding 
while the phospholipid class showed the least change. One exception, how-
ever, is that in the case of IDL lipids, an increase rather than a decrease 
of oleic acid was observed (Table 9) after feeding the SAFF diet. 
Table 8. Fatty Acid Analysis of Rabbit VLDL Lipids after SAFF or COCO Diet Feeding 




















































































aSignificantly different at p < .001 level 
DSignificantly different at p < .01 level 
cSignificantly different at p < .02 level 
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aSignificantly different at p < .001 level 
bSignificantly different at p < .01 level 
csignificantly different at p < .05 level 
tr refers to trace amount (<0. 
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aSignificantly different at p < .001 level 
bSignificantly different at p < .01 level 
cSignificantly different at p < .02 level 
dSignificantly different at p < .05 level 
tr refers to trace amount (0.5%) 




















































































aSignificantly different at p < .001 level 
bSignificantly different at p < .01 level 
cSignificantly different at p < .02 level 
tr refers to trace amount (<0.5%) 
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Section II 
A. Characterization of the Triacylglycerol Hydrolase Activities of Enzyme 
Preparations 
Two separate preparations of triglyceride hydrolase activities from 
chow-fed animals were characterized. Activities from similar preparations 
from animals fed the experimental diets were measured as well. Both arti-
ficial triglyceride emulsions and natural (VLDL) substrates were used. 
The two activities characterized consisted of partially purified lipases 
obtained from post-heparin plasma of either intact rabbits (hereafter re-
ferred to as PHP LPL) or supradiaphragmatic animals (EHP LPL) after the 
injection of sodium heparin (see Materials and Methods). 
1. Enzyme Activities Using VLDL as Substrate: Variation of Substrate 
with Diet 
The triacylglycerol hydrolase activities of both the PHP LPL and 
EHP LPL preparations (d > 1.063 g/ml) were determined using radiolabeled 
VLDL as substrate. Table 12 shows the post-heparin lipase (d > 1.063 g/ml) 
activities of enzyme preparations from rabbits fed the chow diets using 
VLDL from animals fed either the chow or the experimental diets as sub-
strate. These activities were determined in order to test whether the 
VLDL isolated from rabbits fed the experimental diets showed any appreciable 
differences as substrate for the enzyme preparations used. As seen in 
Table 12, the SAFF diet-fed animals' VLDL may be a slightly better substrate 
than the COCO diet rabbit VLDL for both the EHP LPL and PHP LPL activities, 
yet this difference is probably not highly significant. When VLDL from 
chow-fed animals is used as substrate, lipase activities were appreciably 
higher in each case. 
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Table 12. Triacylglycerol Hydrolase Activities of d > 1.063 g/cm3 
Post-heparin Plasma Fractions of Chow-fed Animals Against 
Natural Substrates (VLDL) from Rabbits Fed Either the 
COCO, SAFF, or Chow Diet (Average of Two Determinations) 
Substrate-Enzyme 
Preparation 
SAFF-VLDL - EHP LPL 
SAFF-VLDL - PHP LPL 
COCO-VLDL - EHP LPL 
COCO-VLDL - PHP LPL 
Chow VLDL - EHP LPL 





















2. Characteristics of Enzyme Activities Using Artificial Substrates 
Table 13 contains the post-heparin plasma triacylglycerol hydrolase 
activities from both intact chow-fed rabbits (PHP LPL) and supradiaphrag-
matic chow-fed rabbits (EHP LPL). The enzyme activities of both prepara-
tions increased nearly two times after the d < 1.063 g/ml lipoproteins 
were removed. Consequently all further experiments were conducted after 
removing this fraction of lipoprotein. The activities of these enzyme 
preparations were further characterized according to parameters typically 
used for lipoprotein lipase. These results follow. 
a. PHP LPL Activity 
Substrate concentration was not rate limiting at about 6.2 mM triolein 
in an egg lecithin stabilized emulsion (Figure 11). Under standardized 
assay conditions (see Materials and Methods), the enzyme activity was linear 
with respect to time for at least 60 minutes (Figure 12). After this time 
the activity then decreased presumably due to the inactivation of the enzyme 
at the 370C incubation temperature employed (109). Linearity of the activ-
ity was also noted with increasing amounts of enzyme (Figure 13). A reduc-
tion in the reaction rate was noted, however, when about 8-10% of the trio-
lein substrate had been hydrolyzed. Lastly, the reaction showed a pH optimum 
of about 8.4 (Figure 14). 
b. EHP LPL Activity 
The lecithin stabilized triolein emulsion substrate became rate limit-
ing at about 6.2 mM triolein (Figure 15). The EHP LPL activity was linear 
with respect to time for at least 60 minutes (Figure 16), and with respect 
to enzyme concentration (Figure 17) until the substrate became rate limiting. 
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Table 13. Partial Purification of the Triacylglycerol Hydrolase Enzyme from 
Post-heparin Plasma from Intact and Supradiaphragmatic Chow-fed 





(d = 1.006) 
PHP LPL 
(d > 1.063) 
EHP LPL 
(d = 1.006) 
EHP LPL 
(d > 1.063) 
























Figure 11. Effect of substrate concentration on the post-heparin plasma 
triglyceride lipase activity (d > 1.063 g/ml fraction) from 
intact rabbits (PHP LPL) dialyzed against sodium barbital 
buffer. Enzyme preparations in the amount of 0.04 ml were 
mixed with 0.09 ml of substrate containing the following fi-
nal concentrations: labeled and unlabeled triolein, 0.6-7.9 
umoles/ml; lecithin, 0.51 ymoles/ml; albumin, 1% (w/v), and 
serum, 9% (v/v), in 5 mM sodium barbital buffer, pH 7.4 in 
saline. Final assay volume was 0.2 ml and incubations were 
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Figure 12. Effect of incubation time on the post-heparin plasma trigly-
ceride lipase activity (d > 1.063 g/ml fraction) from intact 
rabbits (PHP LPL) dialyzed against sodium barbital buffer. 
Except for the variation of time of incubation and the use 
of 6.1 umoles/ml final triolein concentration, all conditions 
were as described in Figure 11. 






































Figure 13. Effect of enzyme concentration (mg) on the post-heparin plasma 
triglyceride lipase activity (d > 1.063 g/ml fraction) from 
intact rabbits (PHP LPL) dialyzed against sodium barbital buf-
fer. Appropriate volumes of the enzyme preparations contain-
ing 0.5-5.0 mg protein were incubated with substrate containing 
6.1 umoles triolein/ml in a final assay volume of 0.2 ml. All 
other conditions employed were as described in Figure 11. 
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Figure 14. Effect of pH on the post-heparin plasma triglyceride lipase 
activity (d > 1.063 g/ml fraction) from intact rabbits (PHP 
LPL) dialyzed against sodium barbital buffer. While the pH 
of the substrate preparations and the buffer used was varied 
between 6.8 and 9.2, all other conditions were as described 
in Figure 11. 
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63 72 76 8.0 84 88 92 
PH 
Effect of substrate concentration on the post-heparin plasma 
triglyceride lipase activity (d > 1.063 g/ml fraction) from 
supradiaphragmatic rabbits (EHP LPL) dialyzed against sodium 
barbital buffer. All assay conditions were as described in 
Figure 11. 
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Figure 16. Effect of incubation time on the post-heparin plasma trigly-
ceride lipase activity (d > 1.063 g/ml fraction) from supra-
diaphragmatic rabbits (EHP LPL) dialyzed against sodium bar-
bital buffer. All assay conditions were as described in Fig-
ure 12. 







































Figure 17. Effect of enzyme concentration (mg) on the post-heparin plasma 
triglyceride lipase activity (d > 1.063 g/ml fraction) from 
supradiaphragmatic rabbits (EHP LPL) dialyzed against sodium 
barbital buffer. Appropriate volumes of the enzyme prepara-
tions containing 0.35-3.5 mg protein were incubated with sub-
strate containing 6.1 umoles triolein/ml in a final assay 
volume of 0.2 ml. All other conditions employed were as de-
scribed in Figure 11. 
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Again, a reduction in the rate of reaction was noted when about 8-10% 
of the triolein had been hydrolyzed. The pH optimum for this enzyme prep-
aration was 8.4 as well (Figure 18). 
Assay conditions for subsequent experiments employing either of the 
enzyme preparations were chosen based on the above mentioned results. 
These conditions have been described in detail elsewhere (see Materials 
and Methods), but, unless otherwise stated, reactions were allowed to run 
for 60 minutes at physiological pH and 0.15 M NaCl with enzyme and substrate 
concentrations such that no more than 10% of the triolein was hydrolyzed. 
B. Effect of NaCl on the Triacylglycerol Hydrolase Activities from Different 
Sources 
The effect of pre-incubation with NaCl on the triacylglycerol hydrolase 
activity from different sources can be seen in Figure 19. The enzyme prep-
arations were pre-incubated at 27°C for 60 minutes in the presence of in-
creasing amounts of NaCl, then assayed for lipase activity after adjusting 
the NaCl concentration to 0.15 M. As can be seen in the figure, the 
EHP LPL activity is inhibited approximately 96% at a preincubation NaCl 
concentration of 1.0 M. This finding is consistent with the effect of 
1.0 M NaCl on the lipoprotein lipase enzyme originating in extra-hepatic 
or peripheral tissues (e.g. adipose tissue, cardiac muscle). The PHP LPL 
activity, after preincubating it with 1.0 M NaCl, is inhibited about 53% 
and shows that this preparation contains both hepatic and extra-hepatic 
triacylglycerol lipase activities. The hepatic triacylglycerol lipase ac-
tivity is more resistant to higher NaCl concentrations (53) than the peri-
pheral form. Thus the PHP LPL preparation, which contains both forms of 
lipase activity, is not completely inhibited. As the NaCl concentration 
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Figure 18. Effect of pH on the post-heparin plasma triglyceride lipase 
activity (d > 1.063 g/ml fraction) from supradiaphragmatic 
rabbits (EHP LPL) dialyzed against sodium barbital buffer. 
All assay conditions used were as described in Figure 14. 
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6.8 72 76 8.0 8-4 88 9 2 
PH 
Effect of NaCl concentration on the post-heparin plasma trigly-
ceride lipase activities (d > 1.063 g/ml fraction) from both 
intact and supradiaphragmatic rabbits (PHP LPL and EHP LPL, 
respectively) dialyzed against sodium barbital buffer. The 
equivalent of 0.01 ml of enzyme preparation was used in a to-
tal assay volume of 0.2 ml after preincubation of 0.04 ml of 
enzyme preparation with from 0.1-1.9 M NaCl for 60 minutes at 
27°C. The assay was then conducted after adjusting the NaCl 
concentration to 0.15 M with barbital buffer at 37°C for 1 
hour. The substrate mixture used was the same as that described 
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Is increased past about 1.3 M the lipase activities of both EHP LPL and 
PHP LPL preparations rose progressively. Higher salt concentrations, there-
fore, appear to exert some protective effect on the lipase activity. This 
effect has been previously described for lipoprotein lipase but remains 
unexplained (53). 
C. The Selective Measurement of Peripheral and Hepatic Triacylglycerol 
Hydrolase Activities: Variation of Relative Activity with Diet 
The effect of protamine sulfate concentration on the inhibition of 
triacylglycerol hydrolase activities from the two different sources is de-
picted in Figure 20. Under the assay conditions employed (see caption to 
Figure 20), it was found that prior incubation of enzyme with from 0.4-1.6 mg 
protamine/ml final assay produced maximal preservation of the PHP LPL activ-
ity with simultaneous maximal inactivation of the EHP LPL activity. For 
this reason PHP LPL and EHP LPL preparations (d > 1.063 g/ml) from chow, SAFF, 
and COCO diet-fed rabbits were assayed after preincubation of them with 1.0 mg 
of protamine/ml final assay or 5 mM barbital buffer for 10 minutes at 27°C in 
order to selectively measure the contributions of hepatic and peripheral 
forms of lipase in the PHP preparations of animals on the various diets. 
The results of this experiment can be seen in Table 14. Since it is impos-
sible by this method to inactivate the peripheral form of the enzyme com-
pletely without some reduction of the hepatic form, a correction must be 
made.'- The important trend to note in this table is that in the normal 
rabbit, more than half (57.1%) of the total lipase activity is due to 
Protamine-resistant TGLA = 0.1 (extra-hepatic TGLA) + 0.9(hepatic 
TGLA); protamine-inactivated TGLA = 0.9(extra-hepatic TGLA) = 0.1(hepatic 
TGLA). Thus, hepatic TGLA = 1.125(protamine-resistant TGLA) - 0.125(pro-
tamine-inactivated TGLA); and, extra-hepatic TGLA = 1.125(protamine-
inactivated TGLA) - 0.125(protamine-resistant TGLA). 
Effect of preincubation with increasing amounts of protamine 
sulfate on the inhibition of triglyceride lipase activities 
(d > 1.063 g/ml fraction) from both intact and supradiaphrag-
matic rabbits (PHP LPL and EHP LPL respectively) dialyzed 
against sodium barbital buffer. The equivalent of 0.01 ml of 
enzyme preparation was used in a total assay volume of 0.2 ml 
after preincubation of 0.04 ml of enzyme preparation with 
0.2-2.0 mg protamine/ml final assay for 10 minutes at 27°C. 
The assay was then conducted as described in Figure 11 with 
a triolein concentration of 6.1 umoles/ml. 
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Table 14. Contributions of Hepatic and Extra-hepatic Triacylglycerol Hydrolase Activities to Total 
Post-heparin Plasma Lipase Activity3 (Average of Three Determinations) 
TGL Activity (mU/ml) 
Dietary Group Total PHP LPL Protamine Resistant Protamine Sensitive Hepatic Extra-hepatic 
SAFF 10.7+.5 5.7+,4 5.0+.3 5.8+.l(54.2)b 4.9+.2(45.8) 
COCO 7.3+.6 4.2+.3 3.1+.2 4.3+.2(58.9) 3.0+.2(4l.l) 
Chow 6.3+.4 2.8+.3 3.5+.2 2.7+.l(42.9) 3.6+.2(57.1) 
aAssayed under standard conditions after pre-incubation for 10' at 27°C in 1.0 mg protamine/ml final assay 
bFigures in parentheses are the % contribution of each activity to the total activity 
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the peripheral form of the enzyme. In the experimental group, however, 
the hepatic form constitutes 54.2% and 58.9% of the SAFF diet and COCO 
diet-fed animals' post-heparin plasma lipase activity respectively. It 
should be pointed out, however, that the equations used for the calcula-
tion of the two lipase activities has been worked out in the rat model 
(53). Whether rabbit post-heparin lipase activity behaves similarly has 
not yet been completely verified. In any event, in normal rat post-heparin 
plasma a ratio of peripheral to hepatic-lipase activities has been reported 
to be 1.5:1 (53). In the chow-fed rabbit a ratio of 1.33:1 has been found 
in the above experiment which seems comparable to the rat figure. The 
same ratio in rabbits fed either the SAFF or COCO diet was 0.85:1 and 0.70:1 
respectively. 
Section III 
A. Chemical Composition of VLDL Remnants 
The VLDL (d < 1.006 g/ml) isolated from rabbits fed either chow or the 
experimental diets were incubated in vitro with either EHP LPL, PHP LPL, or 
with normal d > 1.063 g/ml plasma from chow-fed animals for the purpose 
of preparing VLDL remnants (see Materials and Methods), The chemical compo-
sitions of the remnants prepared in this fashion are given below. 
When chow-fed rabbit VLDL were incubated with normal pre-heparin 
(d > 1.063 g/ml) plasma (NPLAS), no appreciable change in chemical composi-
tion of the d < 1.019 g/ml fraction, i.e. the "VLDL remnant" isolated after 
the in vitro incubation, occurred (Figure 21). There was a slight relative 
shift of core components (cholesteryl ester and triglyceride) possibly due 
to exchange or transfer with lipoproteins in the d > 1.063 g/ml fraction. 
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Figure 21. Relative chemical composition of normal chow-fed rabbit VLDL, 
and VLDL after incubation with normal rabbit (d > 1.063 g/ml) 
plasma (NPLAS), intact rabbit post-heparin plasma triglycer-
ide lipase (d > 1.063 g/ml, PHP LPL) or supradiaphragmatic 
rabbit post-heparin plasma triglyceride lipase (d > 1.063 
g/ml, EHP LPL). See Materials and Methods for conditions 
of VLDL remnant preparation. Abbreviations used are as de-
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Yet the surface to core ratio (see Table 15) remained constant (0.50) and 
the VLDL was otherwise unchanged. Figure 21 also shows that when VLDL rem-
nants were prepared by incubating the chow-fed rabbit VLDL with either the 
EHP LPL or PHP LPL preparation, 60% of the original VLDL triglyceride was 
hydrolyzed. Along with this triglyceride depletion, the remnant particle 
became enriched in cholesteryl ester. Additionally remnant phospholipids 
were relatively enriched. Yet in absolute terms, loss of phospholipid oc-
curred (from 27 mg/dl lipoprotein to 20 mg/dl lipoprotein). This relative 
increase in phospholipid is only an apparent one due to the considerable 
loss of triglyceride from the VLDL particle. Lastly, a loss of protein 
(from 10 mg/dl lipoprotein to about 5 mg/dl lipoprotein) occurred while 
the free cholesterol concentration remained the same. No real differences 
in the chemical composition (Figure 21) or surface to core ratios (Table 15) 
were observed however between remnants prepared with either EHP LPL or the 
PHP LPL preparations indicating the possible lack of importance of the 
hepatic lipase in the formation of remnant lipoproteins. 
When either SAFF-fed or COCO-Ied rabbit VLDL were incubated with the 
NPLAS preparation, again no differences in chemical composition were noted 
(Figures 22 and 23). A slight relative shift of the core components, tri-
glyceride and cholesteryl ester, again occurred but this shift was less pro-
nounced than in the chow-fed rabbit VLDL case. Surface to core ratios re-
mained similar, however, indicating no appreciable change in the VLDL after 
incubation with the lipase free preparation, NPLAS. 
VLDL remnants prepared by incubating SAFF diet or COCO diet-fed rabbit 
VLDL with either EHP LPL or PHP LPL preparations yielded about 41% and 44% 
triglyceride hydrolysis respectively, regardless which enzyme preparation 
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Table 15. Surface to Core Ratios of VLDL Remnants Pre-
pared from VLDL of Various Dietary Treatments 
and Enzyme Preparations (Ave. 2 Determinations) 
Enzyme Preparation 
Dietary 
Treatment None NPLAS PHP LPL EHP LPL 
Chow .49 .50 .72 .70 
SAFF .60 .56 .64 .65 
COCO .60 .57 .53 .51 
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Figure 22. Relative chemical composition of SAFF diet-fed rabbit VLDL and 
VLDL after incubation with normal rabbit (d > 1.063 g/ml) plasma 
(NPLAS), intact rabbit post-heparin plasma triglyceride lipase 
(d > 1.063 g/ml, PHP LPL) or supradiaphragmatic rabbit post-
heparin plasma triglyceride lipase (d > 1.063 g/ml, EHP LPL). 
See Materials and Methods for conditions of VLDL remnant pre-
paration. Abbreviations used are as described in Figure 1. 
Standard errors are indicated for n = 5. 
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Figure 23. Relative chemical composition of COCO diet-fed rabbit VLDL 
and VLDL after incubation with normal rabbit (d > 1.063 g/ml) 
plasma (NPLAS), intact rabbit post-heparin plasma triglycer-
ide lipase (d > 1.063 g/ml, PHP LPL) or supradiaphragmatic 
rabbit post-heparin plasma triglyceride lipase (d > 1.063 
g/ml, EHP LPL). See Materials and Methods for conditions of 
VLDL remnant preparation. Abbreviations used are as described 
in Figure 1. Standard errors are indicated for n = 5. 
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was used. These remnant particles became enriched in cholesteryl ester as 
well. It should be noted that the VLDL from rabbits fed either semisynthetic 
diet were already appreciably enriched in cholesteryl esters when compared 
with the chow-fed rabbit VLDL. As in vitro remnant production occurred, 
the VLDL from rabbits fed the semisynthetic diets became further triglyceride-
depleted and cholesteryl ester-enriched. This result indicates the possible 
existence of a continuum of VLDL remnant particles ranging from those only 
slightly triglyceride-depleted to ones considerably poor in triglyceride 
and enriched in cholesteryl ester. Indeed the VLDL from animals fed the ex-
perimental diets may actually be a type of remnant of normal triglyceride-
rich VLDL which for various metabolic reasons are building up in the blood-
stream when experimental diets are fed. 
In the case of VLDL remnants prepared from VLDL of rabbits fed the 
semisynthetic diets, however, both a relative and absolute decrease in phos-
pholipid concentration occurred. Lastly, the absolute level of both protein 
and free cholesterol may have decreased somewhat in the VLDL remnant when 
compared to the VLDL itself. The relative amounts of these constituents, 
however, remained roughly the same (see Figures 22 and 23). 
When surface to core ratios of VLDL remnants prepared from VLDL of 
the various dietary treatments are compared, it can be seen that similar 
ratios occur whether EHP LPL or PHP LPL enzyme preparations are used for 
the in vitro incubations (Table 15). As previously indicated, this phenom-
enon may be due to the fact that the hepatic lipase, present in PHP LPL but 
not EHP LPL preparations, may offer no significant contribution to remnant 
formation. When the surface to core ratios are compared between VLDL and 
its remnant, some differences become apparent. Chow-fed rabbit VLDL was 
the largest VLDL observed with a surface to core ratio of 0.50, while the 
chow-fed rabbit remnant was the smallest particle (surface to core ratio of 
0.72). This result is probably due to the depletion of 60% of the VLDL tri-
glyceride and the concomitant relative increase of surface constituents as 
the triglyceride is lost. The VLDL from rabbits fed the semisynthetic diets 
is by comparison a smaller particle than is the chow-fed rabbit VLDL (see 
Table 15, surface to core ratios of 0.60 from either the COCO or SAFF diet 
rabbit VLDL vs. 0.50 in the chow case). 
A comparison of ratios of remnants in the SAFF and COCO diet cases, 
however, showed the COCO VLDL remnant as having a smaller surface to core 
ratio (0.52) whereas the SAFF VLDL remnants had a value of 0.64 while both 
particles lost a similar amount of triglyceride via hydrolysis (40%). A 
possible explanation is that in the COCO diet-fed rabbit, more cholesteryl 
ester is present in the core of the remnant VLDL yielding a particle with 
larger mean diameter, and smaller surface to core ratio. 
B. Agarose Gel Electrophoresis of VLDL Remnants: Variation with Diet 
Agarose gel electrophoresis of VLDL remnants prepared from VLDL of 
rabbits fed either the chow or SAFF diets and using the EHP LPL enzyme pre-
parations (Figures 24 and 25) predominately showed 8-mobility. Remnants 
prepared using the PHP LPL enzyme preparation, however, showed a mobility 
more intermediate between the typical beta and pre-beta, indicating that 
apolipoproteins are either being lost or perhaps altered making the particle 
somewhat more positively charged. VLDL incubated in the presence of normal 
d > 1.063 g/ml plasma (NPLAS) maintained its pre-8 mobility although some 
exchange or transfer of apolipoproteins (apo C) may have occurred. 
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Figure 24. Densitometric scans of VLDL and VLDL remnants after agarose 
electrophoresis from rabbits fed the chow diet indicating their 
relative mobilities. Conditions were as described in Figure 6. 
Abbreviations are as follows: VLDL, very low density lipopro-
tein; EHP, VLDL remnant formed after incubation of VLDL with 
the supradiaphragmatic rabbit enzyme preparation; PHP, VLDL rem-
nant formed after incubation of VLDL with the intact rabbit en-
zyme incubation of VLDL with the intact rabbit enzyme prepara-
tion; NPLAS, VLDL "remnant" formed after incubation of VLDL 
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Figure 25. Densitometric scans of VLDL and VLDL remnants after agarose 
electrophoresis from rabbits fed the SAFF diet indicating their 
relative mobilities. Conditions and abbreviations are as de-
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Likewise when electrophoresis was performed on VLDL remnants prepared 
from VLDL of rabbits fed the COCO diet, 8-mobility occurred (Figure 26). 
It should be noted, though, that the VLDL from these animals showed g-mobility 
initially so no real net change in mobility occurred. 
The change in mobility from pre-beta to beta might be explained due to 
the loss of apolipoprotein C from the VLDL as triglyceride hydrolysis pro-
ceeded. In addition, as shall be discussed in the next section, a relative, 
and in some cases an absolute, increase in the arginine-rich lipoprotein 
(apo E) also occurred. The net charge on the protein portion of the VLDL 
remnant was probably rendered more positive and less mobile in the agarose 
gel. It can be concluded, however, that as VLDL remnants are produced, a 
lipoprotein particle more closely resembling LDL in its electrophoretic be-
havior on agarose gel occurs. 
C. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis of VLDL 
Remnants: Variation with Diet 
After VLDL remnants were prepared in vitro from VLDL of rabbits fed 
the various diets, an aliquot of each was taken for the purpose of SDS-
polyacrylamide gel electrophoresis. Densitometric scans at 675 nm were 
made of the gels after Coomassie blue staining and the areas under the 
curves corresponding to the apolipoprotein content was determined. Table 
16 contains the results of these experiments. When VLDL from rabbits fed 
any of the three diets was incubated with the NPLAS preparation, no marked 
changes in apolipoprotein composition were noted when compared with the 
apolipoprotein composition of the respective VLDL used. There was some 
loss of apo C peptides, however, probably due to transfer or exchange reac-
tions with the d > 1.063 lipoproteins present in the enzyme preparation. 
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Figure 26. Densitometric scans of VLDL and VLDL remnants after agarose 
electrophoresis from rabbits fed the COCO diet indicating their 
relative mobilities. Conditions and abbreviations are as de-
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Table 16. % Composition of Apo VLDL Remnants Prepared from VLDL 
of Rabbits Fed Various Diets (Ave. 2 Determinations) 


















































When the EHP LPL or PHP LPL enzyme preparations were utilized for the pre-
paration of remnant lipoproteins, a marked loss of apo C peptides occurred 
with a relative increase in the apo B peptides. In the case of remnants 
prepared from VLDL of rabbits fed either the chow or the SAFF diet, rela-
tive increases in the arginine-rich peptide of the apolipoprotein also 
occurred. The significance of these results is that as remnants are formed, 
the apo B and arginine-rich peptides are retained, while apo C peptides are 
preferentially lost, possibly due to exchange or net transfer to HDL in the 
incubation media. 
When VLDL remnants prepared from rabbits fed the COCO diet were sub-
jected to SDS-polyacrylamide gel electrophoresis, however, a relative de-
crease in apo C and a slight decrease in the arginine-rich peptide occurred. 
It appears, therefore, that while the apo B peptide is retained in the rem-
nant particle, some loss of the arginine-rich peptide is taking place. It 
remains to be determined whether this slight loss is statistically signif-
icant, since the electrophoresis performed is the result of only two deter-
minations. 
D. Fatty Acid Composition of Lipid CLasses of VLDL Remnants: Variation 
with Diet 
The results of fatty acid analysis of VLDL remnant lipids after incu-
bation with the PHP LPL or EHP LPL preparations or with the normal plasma 
preparation are given in Tables 17, 18 and 19. 
From the fatty acid compositional data obtained, it appeared that no 
real differences exist as far as the phospholipid and cholesteryl ester 
fractions are concerned. Cholesteryl esters have been reported to transfer 
between HDL and VLDL in human plasma (110), so whatever differences might 
Table 17. Fatty Acid Analysis (Mean %) of Lipid Classes of VLDL Remnants Prepared from 
VLDL of Rabbits Fed the Chow Diet! Variation with Enzyme Preparation 































































































tr refers to trace amount (<0.5%) 
Table 18. Fatty Acid Analysis (Mean %) of Lipid Classes of VLDL Remnants Prepared from 
VLDL of Rabbits Fed the SAFF Diet: Variation with Enzyme Preparation 









































































































tr refers to trace amount (<0.5%) 
Table 19. Fatty Acid Analysis (Mean %) of Lipid Classes of VLDL Remnants Prepared from VLDL of 
Rabbits Fed the COCO Diet: Variation with Enzyme Preparation (Average of Two 
Determinations) 
Triglycerides Phospholipids Cholesteryl Esters 






































































































tr refers to trace amount (<.05%) 
125 
exist in the fatty acid composition may be at least partially the result 
of transfer or exchange reactions since HDL was present in the enzyme pre-
parations used. This phenomenon is also true with regard to the phospho-
lipid fractions as well, but in addition, phospholipase activity associated 
with the lipoprotein lipase enzyme could also be responsible for fatty acid 
composition differences. 
While this data represents only the average of two determinations, it 
appears that, in the phospholipid and cholesteryl ester classes, minor var-
iations among the content of oleic acid in the SAFF and chow diet cases and 
among the linoleic acid in the COCO diet case occurred. VLDL remnants pre-
pared by incubating VLDL with the d > 1.063 g/ml fractions of normal plasma 
also showed some small fatty acid composition differences as well. 
In the case of the relative fatty acid content of the triglyceride 
fraction of VLDL remnants, a few trends became apparent. In the SAFF (and 
chow) cases, it appeared that a loss of linoleic acid (18:2) occurred dur-
ing remnant preparation, while the saturated fatty acids, palmitate and 
stearate increased only slightly in relative content. This trend was not 
observed, however, in the COCO diet case. 
IV. DISCUSSION 
The semisynthetic diet, high in saturated fat (COCO), produced a marked 
effect on the serum lipid concentrations of rabbits. When compared with the 
high unsaturated fat semisynthetic diet (SAFF), the COCO diet produced a 
notable hypercholesterolemia with both plasma free and esterified choles-
terol being elevated. Plasma lipoproteins showed an increase of serum VLDL, 
IDL and LDL in the COCO diet case as well (i.e. those lipoproteins with 
d < 1.063 g/ml). Only a slight decrease in serum HDL levels was observed 
after feeding the experimental diets but the HDL level was lowest in the 
COCO diet case. The COCO diet used has been shown to be atherogenic in 
rabbits by others (80-83) and indeed when thoracic aorta segments from rep-
resentative animals of each dietary group were stained with fat red 7B, 
the ones from rabbits fed the COCO diet had more grossly visible athero-
sclerotic plaque accumulations than aortas from SAFF-fed animals, which 
contained some lesions, or from chow-fed rabbits, which showed no gross 
lesions. 
Since the animals in this study were used as their own controls, only 
two rabbits were sacrificed after feeding the SAFF diet and before the COCO 
diet was begun. Consequently assessing the degree of atherogenicity of the 
two experimental diets grossly was difficult. Yet in comparing the few 
aortas which were dissected and stained, it was felt that the COCO diet 
yielded larger, more extensive areas of plaque accumulation than after feed-
ing the SAFF diet. The results of the blood chemistries (i.e. hypercholes-
terolemia) and the differences in the characteristics of the serum lipopro-
teins of rabbits fed the two diets further strengthens the concept of the 
high saturated fat diet as being more atherogenic. It should be mentioned 
that the SAFF diet, while producing fewer changes in the serum cholesterol 
and lipoprotein concentrations, is also atherogenic when compared to chow. 
A possible explanation of this is not only due to the high fat loading of 
the rabbits via the diet, but also due to the presence of casein and sucrose, 
which are more atherogenic materials than other protein and carbohydrate 
sources (86, 111). The important difference is that when hydrogenated coco-
nut oil is used as the fat source, more significant changes are occurring. 
These changes will next be discussed. 
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Numerous investigators have found that the serum VLDL of hypercholes-
terolemic rabbits are rich in cholesteryl ester and relatively poor in tri-
glyceride (21, 78). This effect has been shown in rabbits supplemented 
with either cholesterol alone or cholesterol plus fat from various sources. 
Evidence is presented here for the occurrence of cholesteryl ester enriched 
VLDL (d < 1.006 g/ml) in rabbits fed semisynthetic diets totally free of 
cholesterol and high in fat. The cholesterolemic effect of these diets is 
more marked in the case of feeding highly saturated fat than when the poly-
unsaturated fat diet was fed. 
The five major changes consistently observed in the serum lipoproteins 
after cholesterol feeding (60) have been compared to the result of feeding 
both the COCO and SAFF diets to rabbits (see Results, Table 9). In the 
COCO diet case, HDLC was not found to be present among the serum lipopro-
teins. One possible explanation for the occurrence of HDLC, when it does 
occur in the cholesterol-induced hyperlipoproteinemia situation, is that the 
HDLC are formed by an overloading of typical HDL with cholesterol (60). When 
the COCO diet was fed, serum cholesterol values, while significantly high 
when compared with chow, were not as high as when cholesterol supplementa-
tion is used. Thus cholesterol overloading has probably not yet occurred. 
This difference, therefore, may help to explain the initial changes in lipo-
protein alteration and serum chemistries seen in the atherogenic process. 
The HDLC may occur at a later stage of the disease. 
In order to begin to pinpoint which factor or factors might be involved 
in the increased atherogenicity of the COCO diet over the SAFF diet, a com-
parison of the entries in Table 9 of Results is helpful. The lipoproteins, 
IDL, HDL and HDLC all show no marked difference whether the COCO or SAFF 
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diet was fed (IDL increases, HDL decreases, and HDL is absent). However, 
in the COCO-fed case, B-VLDL is present and LDL is increased, while when 
the SAFF diet is fed, no B-VLDL is seen and LDL actually decreases somewhat. 
Although increases in LDL levels have been implicated to a large extent in 
atherogenesls (45, 77), the presence of altered VLDL, the B-VLDL, may indeed 
be equally as important, especially since a precursor-product relationship 
between VLDL and LDL has been demonstrated (60, 73, 112). 
In summary, the beta-mobility of the COCO diet-fed rabbit VLDL seen 
on agarose gels in this study indicates the presence of an altered lipopro-
tein particle which may be important in atherogenesis. While the SAFF diet-
fed rabbit VLDL's chemical composition was altered toward a cholesteryl es-
ter rich particle, its mobility on agarose remains pre-beta. In addition, 
the serum cholesterol and cholesteryl ester concentration in the case of 
rabbits fed the SAFF diet, while higher than the chow-fed animals' sera, 
was appreciably lower than serum after the COCO diet feeding. Lastly, LDL 
levels in rabbits fed the SAFF diet were about the same as in the chow-fed 
case, while an increased LDL concentration was seen when the COCO diet was 
fed. Thus, the SAFF diet appears to be exerting some degree of prevention 
against hypercholesterolemia, hyperlipoproteinemia, and VLDL modification, 
all of which when present may be atherogenic. 
This effect may be explained by the finding that when saturated 
fatty acids are used to perfuse isolated rat liver (68), the molar ratio 
of cholesterol to triglyceride in the VLDL secreted was greater than when 
either oleic or linoleic acids were used. Thus the COCO diet, by virtue 
of its high saturated fat content, resulted in the stimulation of cholestero-
genesis and the subsequent incorporation of this cholesterol into the secreted 
lipoprotein. 
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Consistent with this presumed increased amount of cholesterol synthesis 
is the finding that both different relative and absolute amounts of apolipo-
proteins are present in the VLDL of rabbits fed the experimental diets. 
One particular apo VLDL peptide was markedly increased with respect to the 
other apo VLDL peptides normally present in VLDL. This peptide is similar 
in mobility on polyacrylamide gels to that found by Shore et al. (78) in 
cholesterol-fed rabbits which was determined to be arginine-enriched. In 
the COCO diet case, this peptide accounted for almost 40% of the total 
VLDL apoprotein content, nearly a five-fold increase when compared to the 
chow diet. A similar result was observed, but to a lesser extent, after 
the feeding of the SAFF diet to the rabbits. 
This finding may be responsible for the decreased mobility of the 
COCO diet VLDL on the agarose gels in that the greater amount of the 
arginine-rich peptide, a positively charged species at the pH employed, 
migrates less toward the anode during electrophoresis than normal VLDL. Ad-
ditionally, this observation is consistent with the suggestion made by 
Shore et al. (78) that the arginine-rich peptide is one of the apolipopro-
teins primarily involved with cholesterol transport and metabolism. The 
parallel increases in cholesteryl esters in the VLDL and the arginine-rich 
peptide(s) is suggestive of the peptide functioning as a binding protein 
specific for cholesteryl esters (or some complex of these esters with other 
lipids). 
In any event, the diet-induced situation in the rabbit reported here 
appears similar to findings reported after the cholesterol feeding of rab-
bits (78) and it may be analogous to the lipoprotein profile seen in human 
type III hyperlipoproteinemia (73). In this condition early atherosclerotic 
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lesions are accompanied by an increased amount of cholesteryl esters in the 
VLDL and contain increased amounts of the arginine-rich peptide as well. 
The significance of these present studies, therefore, is that while no di-
etary cholesterol was provided, in response to a high saturated fat diet 
rabbits assembled altered VLDL with similar properties as VLDL made under 
conditions of both cholesterol-induced hyerplipoproteinemia and human type 
III hyperlipoproteinemia. 
Zilversmit has concluded that the lipoproteins which are high in 
cholesteryl ester and poor in triglyceride appear to originate from either 
chylomicrons or VLDL and are possibly important in atherogenesis (118, 119). 
These particles may indeed be atherogenic, yet the results of experiments 
presented here and those of Shore et al. (78) as well suggest that the rem-
nants prepared from the d < 1.006 g/ml serum lipoprotein fraction may be 
derived from VLDL which has originated via liver synthesis. 
According to Zilversmit (21), two-thirds of the cholesteryl ester com-
ponent of VLDL is derived from chylomicron degradation. While this choles-
teryl ester is of intestinal origin, these results do not necessarily sup-
port the idea that these particles are the direct result of chylomicron 
metabolism. Cholesteryl esters have been reported to exchange and transfer 
between HDL and VLDL (110). In addition, chylomicron remnant cholesteryl 
ester is metabolized in the liver (113) and these components may then be 
reassembled into VLDL and perhaps HDL as well. Consequently, the altered 
VLDL may not be chylomicron remnants per se even though part of their choles-
teryl ester component has its origin in the chylomicron. 
Lastly, the apolipoprotein composition of the altered VLDL also indi-
cates that these particles are not merely remnants of chylomicron or VLDL 
catabolism. In the present studies, VLDL remnants prepared in vitro from 
chow-fed rabbit VLDL, while lower in relative apo C content, showed no ap-
preciable increase in the arginine-rich peptide. Other studies (114-118) 
have shown that after cholesterol supplementation of experimental animals, 
altered VLDL are observed with a high arginine-rich peptide content as 
well. Thus, the altered VLDL may be derived from a unique VLDL species 
enriched in the arginine-rich peptide and originating in the liver. 
After the intravenous injection of heparin, it is possible to measure 
in plasma the activities of two different triglyceride hydrolases (trigly-
ceride lipase): lipoprotein lipase from peripheral tissues and hepatic 
lipase. 
Enzyme preparations from both intact chow-fed rabbits (containing peri-
pheral and hepatic lipases) and supradiaphragmatic chow-fed rabbits (con-
taining the peripheral lipase) were assayed with VLDL from the various di-
ets as substrate. When VLDL from chow-fed animals was used as substrate, 
lipase activities were appreciably higher in each case. This finding indi-
cates that the VLDL from experimentally-fed animals is not as effective a 
substrate for the triacylglycerol hydrolase enzyme as the chow-fed rabbit 
VLDL. Consequently a build-up of partially catabolized VLDL may be occur-
ring in the circulation of animals when fed the experimental diets. The 
observation that serum from the COCO diet-fed animals was lipemic is con-
sistent with this concept. A second explanation is that the VLDL of rabbits 
fed the experimental diets is cholesteryl ester-enriched and triglyceride-
poor (both of these molecules are core constituents of VLDL). Consequently, 
the triglyceride component may somehow not be as available to the enzyme 
as normal chow VLDL triglyceride. 
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When surface to core ratios are calculated from compositional data 
of lipoproteins, a rough idea of particle size can be obtained (35, 72). In 
general, the larger the ratio, the smaller the respective particle will be. 
Lipase activities have been reported to be greater when VLDL or chylo-
micron particle size is larger (120) (i.e. when they contain more triglycer-
ide in relation to their surface constituents). The activities of the en-
zyme preparations used in this study should therefore be equal as far as 
the VLDL substrate from either the SAFF or COCO-fed animals is concerned 
and indeed they are. Further, when chow-fed rabbit VLDL is the substrate, 
which has a lower surface to core ratio than either COCO or SAFF diet-fed 
VLDL, higher lipase activities were observed, attesting to the usefulness 
of the surface to core ratio in predicting lipase activity. 
The two enzyme preparations from different sources were characterized, 
and were found to exhibit similar properties under the assay conditions em-
ployed. Linearity of the activity, pH optima, and rate limiting substrate 
concentrations were all nearly identical whether the intact or supradia-
phragmatic rabbit preparation was assayed. The peripheral lipase, however, 
is inhibited by 1.0 M NaCl and by protamine (55) while the hepatic lipase 
is insensitive to these conditions (121). Consequently, the supradiaphrag-
matic enzyme preparation showed nearly 100% inhibition of lipase activity 
when preincubated with either 1.0 M NaCl or 1.0 mg protamine sulfate. The 
enzyme preparation from intact rabbits, as expected, was only partially 
inhibited due to contributions of enzyme activities from the peripheral 
tissues as well as the liver. 
When the selective measurement of hepatic and peripheral enzyme activ-
ities of intact rabbits fed the experimental diets was made and compared 
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with chow-fed animals, a change in the relative contributions of the two 
lipase activities to the total activity became apparent. In chow-fed ani-
mals, more than half of the total enzyme activity was due to the peripheral 
lipase. In the experimental groups, it was the hepatic lipase which ac-
counted for more than half of the total post-heparin plasma lipase activ-
ity. What may have happened in this case is either an absolute increase 
in the hepatic lipase or a decrease in the activity of the peripheral en-
zyme. In the rat, is has been shown that the ratio of peripheral to hepatic 
lipase in post-heparin plasma is 1.5:1 (53) whereas in these experiments a 
value of 1.33:1 was calculated. This same ratio of activities in rabbits 
fed either the SAFF or COCO diet was 0.85:1 and 0.70:1 respectively. Whether 
these ratios correspond to a decrease in peripheral lipase activity or an 
increase in the hepatic form awaits the methodology of determining absolute 
triglyceride lipase activities in post-heparin plasma. It does appear, how-
ever, that since an increase in the d < 1.063 g/ml lipoprotein fraction has 
occurred in the experimental diet-fed case, a decrease in the peripheral 
lipase, important in the catabolism of these particles, may have occurred. 
Although the hepatic lipase has the capability of hydrolyzing a variety 
of substrates (e.g. monoglyceride, diglyceride, triglyceride and phospholipid) 
in vitro, it is presently an enzyme in search of function with regard to 
lipoprotein metabolism in vivo (112). Consequently, it was felt that the 
in vitro preparation of VLDL remnants using both intact and supradiaphragmatic 
enzyme preparations might shed some further light in the role of the hepatic 
lipase. However, no real differences in the chemical composition or surface 
to core ratios were observed between remnants prepared with either the supra-
diaphragmatic or intact rabbit enzyme preparations. This result is 
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consistent with the suggestion that the hepatic lipase is not important in 
the formation of remnant lipoproteins (122). 
The preparation of VLDL remnants from VLDL of rabbits fed the various 
diets was carried out in order to provide further information about the 
catabolism of both the altered and normal lipoprotein particles obtained 
via the dietary manipulation. The VLDL remnants prepared from chow-fed 
rabbit VLDL were triglyceride-poor and cholesteryl ester-enriched. Loss 
of phospholipid and protein occurred while the free cholesterol concentra-
tion remained unchanged. In addition, the mobility of the remnant lipopro-
teins on agarose was, for the most part, beta. By contrast, the VLDL from 
which these remnants were prepared were pre-beta in mobility indicating 
some loss or alteration of the protein moiety. Lastly, the surface to core 
ratios indicate that the remnant lipoprotein is a smaller particle than the 
VLDL from which it was prepared. 
These results suggest that the cholesteryl ester-rich, triglyceride-
poor VLDL observed after feeding the COCO or SAFF diets may be remnants 
of triglyceride-rich particles which are building up in the circulation 
(73). However, as previously discussed, the relative composition of the 
apolipoproteins of VLDL from the experimental diet-fed animals and that 
of the VLDL remnants from chow-fed rabbits is incompatible with this con-
cept. While apo C peptides are lost from the VLDL as remnants are formed, 
the content of arginine-rich peptide(s) in the chow-fed rabbit VLDL rem-
nants is in no way as high as that in the VLDL from the COCO diet (or for 
that matter the SAFF diet). Therefore, since the arginine-rich protein 
is only present in small amounts (<10% of the total apolipoprotein) in serum 
VLDL, it is likely to be present in only small amounts in remnant particles 
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formed from this VLDL. Additionally, surface to core ratios are not a 
completely accurate measure of particle size (35) and the slight differences 
found among the normal and altered VLDL may not be real. A more accurate 
measure of particle size is via electron microscopy. The work of Shore 
et al. (78) has shown that VLDL from rabbits made hyperlipoproteinemia with 
cholesterol has a larger mean particle diameter than normal chow-fed rabbit 
VLDL. If the experimental diet-fed rabbit VLDL consisted primarily of VLDL 
remnants, they would be expected to be smaller, not the same size or larger, 
than the VLDL from which they are formed. Further work is needed (i.e. 
electron microscopy) before a definite conclusion in the case of the experi-
ments reported here can be reached. 
The VLDL from either SAFF-fed or COCO-fed rabbits is already appreciably 
cholesteryl ester-enriched, and triglyceride-poor. Yet when remnants were 
prepared using either of these VLDL, it became further triglyceride-
depleted and cholesteryl ester-enriched. This result suggests the existence 
of a continuum of VLDL and remnant particles ranging from those only slightly 
triglyceride-depleted to ones considerably poor in triglyceride and rich 
in cholesteryl esters. 
Both the COCO and SAFF diet-fed rabbit VLDL had similar surface to core 
ratios. Compositional analyses of the lipoprotein showed the VLDL from the 
SAFF diet case to contain more triglyceride and less cholesteryl ester 
than the VLDL obtained after feeding the COCO diet. Yet the sum of these 
two core components was identical in each case. Remnants prepared from 
these VLDL yielded particles with different surface to core ratios, the 
COCO diet VLDL being smaller. Since both VLDL lost 40% of their respective 
triglyceride content, the additional amount of cholesteryl ester in the case 
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of the COCO diet VLDL remnants may account for the larger mean diameter of 
this particle. The size of these particles may be related to their accumu-
lation in the circulation in the event that their metabolism and subsequent 
utilization is somehow slowed or prevented. 
The fatty acid composition of the VLDL, as expected, was found to 
reflect that of the diets fed. In general, the percentages of palmitate 
and oleate were significantly decreased during the feeding of the polyunsat-
urated fat diet (SAFF) while linoleate was consistently increased in each 
lipid class. 
It has been previously reported that when rat liver was perfused with 
palmitic acid, the secreted VLDL had a lower percentage of triglyceride and 
a higher percentage of cholesterol and phospholipid than did the lipoprotein 
produced when oleate or linoleate was infused (123). It remained to be deter-
mined whether these observations could be extended to a general relationship 
describing the effects of saturated and unsaturated free fatty acids on the 
production and properties of VLDL. The fatty acid and chemical compositional 
data of the VLDL obtained after feeding the SAFF and COCO diets in these ex-
periments are in agreement with these in vitro liver perfusion experiments. 
When the saturated fat diet was fed, less triglyceride and more phospholipid 
and cholesterol were present in the resultant VLDL. Additionally, this 
VLDL triglyceride contained proportionately more palmitic acid than the 
SAFF diet-fed rabbit VLDL which was enriched in linoleic acid. 
It is probable that phospholipid and cholesterol are required to effect 
some specific configuration of the VLDL which, along with the apopeptides, 
allows it to carry the fat soluble triglyceride in the aqueous environment 
of the blood. The polar, hydrophilic groups of these molecules undoubtedly 
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participate in this function. Palmitic acid (mp 63.1) is solid at room 
temperature and has a higher melting point than does oleic acid (mp 13.4) 
or linoleic acid (mp 16.5). Furthermore, the solubility of linoleic or 
oleic acid in polar solvents exceeds that of palmitic acid. These differ-
ences in physical properties may mean that more of the polar cholesterol 
and phospholipid are required to stabilize the VLDL when it contains a 
greater proportion of its triglyceride fatty acids as palmitate than lino-
leate. 
In summary, then, since diets high in saturated fats preferentially 
yield VLDL which contains a higher ratio of cholesterol and phospholipid 
to triglyceride, and since these lipoproteins may be either used at a slower 
rate (as previously mentioned) or in some way allowed to build up, it might 
help explain both the lipid lowering effect of unsaturated fat diets and 
the more atherogenic nature of the COCO diet used in this study. 
Only minor differences in the fatty acid composition of the VLDL rem-
nants occurred when compared to its respective VLDL. One observation, how-
ever, warrants further consideration. In the SAFF (and chow) fed cases, a 
loss of linoleic acid occurred during remnant preparation while the saturated 
fatty acids, palmitate and stearate increased slightly in relative content. 
This result was not observed in the COCO diet case indicating no chain-length 
specificity of the lipase under these conditions. Chain-length specificity 
of the triglyceride lipase enzyme has not been thought to be a characteristic 
of this system. Recent work by Hulsmann et al. (124), however, has indicated 
a higher rate of hydrolysis of monolinoeoylglycerol by a heparin releasable 
liver lipase than when monopalmitoylglycerol was used. Under the conditions 
of high polyunsaturated fat diets used in the present study, there may be 
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some preferential hydrolysis of linoleic acid by the triglyceride lipase 
preparation as well. This preferential hydrolysis may contribute to the 
faster utilization of polyunsaturated fatty acids in vivo and consequently 
to the hypolipidemic effect of dietary polyunsaturated fats. 
V. SUMMARY 
New Zealand white rabbits were successively maintained on normal chow, 
a semisynthetic diet high in polyunsaturated fat (safflower oil; SAFF diet) 
and a semisynthetic diet high in saturated fat (hydrogenated coconut oil; 
COCO diet) for 9 weeks each. 
The g-mobility of VLDL on agarose from rabbits fed the semisynthetic 
diet high in saturated fat and containing no cholesterol indicates the pres-
ence of an altered lipoprotein particle which may be atherogenic. In addi-
tion, this VLDL was cholesteryl ester-enriched and triglyceride-poor. This 
alteration is perhaps regulated by the stimulation of de novo cholesterogenesis 
in the liver. Although a similar effect has been reported after the choles-
terol feeding of rabbits, the significance of the present studies is that 
while no dietary cholesterol was provided, an altered VLDL is produced with 
similar properties as those seen under conditions of both cholesterol-induced 
and human type III hyperlipoproteinemias. 
Other effects of this diet are an increase in the d < 1.063 g/ml frac-
tion of lipoprotein especially VLDL and LDL2 and a decrease in the HDL frac-
tion. Hypercholesterolemia is also observed. 
When a similar diet, high in polyunsaturated fat, was fed, the VLDL also 
became cholesteryl ester-enriched and triglyceride-poor but it remained pre-
beta in its mobility on agarose gels. In addition, this diet appeared to 
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offer some degree of protection against the hypercholesterolemia and hyper-
lipoproteinemia effects of the high saturated fat diet. 
Partially purified triglyceride lipase activities from post-heparin 
plasma of both intact and supradiaphragmatic rabbit preparations were char-
acterized using triglyceride emulsions as substrate. The preparations from 
intact rabbits contained both the hepatic and peripheral forms of triglycer-
ide lipase. Selective measurement of these activities was carried out due 
to the almost complete inhibition of the peripheral lipase in the presence 
of protamine sulfate. The supradiaphragmatic enzyme preparation contained 
only the peripheral form of this lipase activity. 
When radio-labeled VLDL from experimentally-fed animals (using semi-
synthetic diets high in either saturated or unsaturated fat) were used as 
substrate for the above mentioned enzyme preparations, similar activities 
were observed whether preparations from intact or supradiaphragmatic rabbits 
were used. However, activities were lower than when normal chow-fed rabbit 
VLDL was assayed indicating that the VLDL from experimentally-fed animals 
is not as effective a substrate for the lipase enzyme. As a result, a 
build-up of the VLDL has been hypothesized under those dietary conditions 
which may be atherogenic. This finding is also consistent with the particle 
size of the various VLDL as estimated by surface to core ratios, the larger 
particles (i.e. chow-fed rabbit VLDL) being catabolized more rapidly. 
The selective measurement of hepatic and peripheral triglyceride lipases 
from post-heparin plasma enzyme preparations of intact rabbits indicated a 
change in the relative contribution of the two lipase activities among the 
dietary groups. A relative decrease in the contribution of the peripheral 
lipase in the experimental diet-fed rabbit was observed. This decrease may 
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be important in that a build-up of altered VLDL particles in the circula-
tion is occurring, accounting in part for the atherogenicity of the experi-
mental diets. 
The preparation of VLDL remnants from VLDL of rabbits fed the various 
diets was carried out in order to provide further Information about the 
catabolism of both the altered and normal lipoprotein particles. The rem-
nants prepared from chow-fed rabbit VLDL were triglyceride-poor and choles-
teryl ester-enriched. Loss of phospholipid and apo C peptides occurred 
while the free cholesterol content remained about the same. In addition, 
the mobility of these remnants on agarose was, for the most part, beta, 
while the VLDL originally showed pre-beta mobility. 
This result suggested that the VLDL isolated from rabbits fed either 
the high saturated or high polyunsaturated fat diets may be remnants of 
normal triglyceride-rich VLDL. However, the apolipoprotein content of 
this altered VLDL is such that it may be a unique lipoprotein derived via 
synthetic processes in the liver. Further work is necessary before the 
origin of this altered VLDL particle can be accurately determined. 
The VLDL from either SAFF-fed or COCO-fed rabbits was already appre-
ciably cholesteryl ester-enriched and triglyceride-poor. Yet when remnants 
were prepared using either of these VLDL, it became further triglyceride-
depleted and cholesteryl ester-enriched. Surface to core ratios of these 
VLDL remnants were different, indicating that the COCO diet-fed rabbit VLDL 
remnant was a larger particle than that in the SAFF case. Although both 
VLDL lost about 40% of their respective triglyceride content, the additional 
amount of cholesteryl ester in the case of the COCO diet VLDL remnants may 
account for this larger particle. The size of these particles may be 
140a 
related to their accumulation in the circulation in the event that their 
metabolism and utilization is somehow slowed or prevented. 
Finally, the fatty acid composition of the VLDL was, in general, found 
to reflect that of the diets fed. The fatty acid composition of VLDL rem-
nants, however, showed preliminary evidence for the preferential hydrolysis 
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